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Nucleic acid aptamers are promising alternatives to antibodies for a wide array of 
diagnostic and therapeutic applications. However, state-of-the-art aptamers suffer from 
poor pharmacokinetics and diversity, limiting their affinity and specificity for many 
therapeutically relevant targets. The emerging field of glycoscience provides 
opportunities to improve the utility of aptamers over antibodies. Combining synthetic 
chemistry with modern molecular biology and polymer science, the synthesis of Xeno 
Nucleic Acid monomers and chemoenzymatic polymerization via engineered polymerase 
enzymes allows the production of nucleic acid drugs with superior resistance to 
endogenous nucleases. The modular structure of nucleic acids provides for the design of 
sequence-defined polymers capable of post-synthetically appending complex synthetic 
glycans, extending the catalytic geometry of aptamers. Our SELEX inspired FACS based 
particle display approach allows for high-throughput screening. Additionally, we expect 
this method has the capability of screening aptamers in human serum. 
Our synthetic approach utilizes a Sonogashira cross-coupling reaction to install a 
flexible alkyne to the major groove of 2′-deoxy-2′-fluoro-arabinose uracil base. By 
incorporated recent advances in nucleic acid synthesis, one-pot nucleobase activation and 
sugar glycosylation is achieved and bis-oxybenzyl phosphoamidite synthesis can afford 
gram scale HPLC-free purification of the triphosphates. The FANA C8-alkyl-uridine 
triphosphate will be incorporated by an engineered Tgo DNA polymerase to allow 
systematic introduction of alkynyl conjugation handles into a DNA-templated FANA 
polymer. Subsequent conjugation with azido-modified glycans via the Huisgen copper-
catalyzed alkyne-azide cycloaddition (CuAAC) click reaction will generate sequence 
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In the wake of the “protein-drug revolution” a new frontier of drug amiable 
chemistries has begun gaining traction, stemming from the foundations of traditional 
small molecule organic synthesis and biochemistry- nucleic acid and glycomimetic 
therapeutic agents. These new models of study are very well suited to the emerging field 
of Chemical Biology, where a deep understanding of organic chemical synthesis and 
Biochemistry does more than just empower biological research, as per biological 
chemistry, but highly suggests even demands not just the analysis but also development 
of novel biological polymers. Although there are significantly developments worth noting 
in the development of synthetic peptides, aptly named polyamides, as per the amide bond 
linking joining each monomer, or more exotically as xenoproteins 1; however, at the core 
of these developments is a sense of ‘similarity’ to natural proteins or the ability to 
augment natural systems to include unnatural amino acids (UAAs), either pre-/post-
synthetically or in vivo systems through directed evolution. A light etymological analysis 
suggests a reason as to perhaps why there is a subsequent distance between the adoption 
of the term xeno in the context of proteins- stemming from the Ancient Greek ένος 
(xénos) for stranger or foreigner, this affix contextually describes any species that 
exhibits unusual characteristics from within their class; surely, since proteins are arguably 
the state-of-the-field in biotechnology and modification of amino acid into varying 
flavors of β or γ linked side chains does little to obfuscate the similarity of protein-like 
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polymers. This is perhaps why the term xeno nucleic acid (XNA) has found moderately 
more acceptance in literature.  
 
Advantages of XNA Technology over Traditional Nucleic Acids 
 
While it is attractive to believe that the foundations of XNA research stem from 
the discovery of ribozymes, RNA molecules capable of acting similarly to proteins as the 
‘functional’ elements of life and not necessarily as purely ‘informational,’ the true origins 
are more-likely to be in the creativity of early 20th century chemists and partially rooted 
in the discovery of the structure of DNA 2,3. While certainly there is something to be said 
concerning ribozymes’ ability to have the same chemical species, act up- & down-stream 
in molecular biological central dogma, XNA polymers have technological value due to 
three key factors: 1) multi-stranded character of nucleic acids allows redundant self-
encoding; 2) modular design composed of generally three main motifs- nucleobase, sugar 
ring, and backbone linkage; & 3) single duplex stabilization, through dihedral angles or 
π–π stacking.  
The multi-stranded character of nucleic acids is best known by Watson, Crick, 
and Franklin double helix model 4,5; yet, the amphiprotic characteristics of nucleic acid 
bases also allows the formation of triplex helices through a combination of Watson-Crick 
and Hoogesteen base pairing of multiple base-pairs 6, given the correct sequence or 
modified chemical backbone such as aminoethyl glycine Peptide Nucleic Acid (aegPNA) 
7–9. Biologically, each strand of the double helix allows nucleic acids to have the unique 
property to self-template their partner strand, allowing sequence-specific replication of 
the genetic information of a living system through a sort of insured “self-redundancy.” 
This also provides for flexibility to polymer by defining an ability to specifically identify 
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a target, biologically its own complement strand, but this need not necessarily be the 
case. Indeed, this is the structural basis of aptamer technology. Additionally, the ability 
for nucleic acids to form complex secondary structure triplexes with similar sequences of 
nucleotides is a common feature within transfer RNA (tRNA) nucleotides and forms the 
basis of the development of minor-groove Triplex Forming Oligonucleotides (TFOs) for 
the purpose of specific DNA duplex interaction and subsequent gene silencing 10,11, 
similar to function of natural triplex and G-quadraplexes within genetic Untranslated 
Regions (UTRs) notable telomeres 12,13. Perhaps then it is no surprise that even Linus 
Pauling and his contemporaries considered a triplex helix structure 14,15. Hence, 
modification of natural nucleic acid bases has also allowed the generation of even higher 
unnatural multiplexes 16. 
This is possible due to the modularity of nucleic acids as a polymer. While the 
term XNA seemed to have stemmed originally from an xNA denotation the different x 
sugar ring incorporated within a specific species of nucleic acid, such as D for 
deoxyribose or R for Ribose, this term has grown in scale to essentially detonate any 
unnatural/synthetic nucleic acid structure- including modified bases and backbones, 
regardless of their authors’ original intentions 17,18. This “XNA Zoo,” so-to-speak, exists 
because nucleic acid structures are generally tolerant of modification to each of the three 
elements in a mutually exclusive manner; some even going so far as to classify any 
possible XNA as existing along a three-dimensional modified base, sugar, backbone 
continuum 19. This arguable classifies XNA as a side-chain polymer with respect to their 
sugar moieties, which are mainly responsible for determining the steric effects and thus 
thermal stability of XNAs 20 
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The sugar ring of XNAs are a likely contributor to the ability for XNAs to form 
stable helices, as it is a well-known phenomenon that polysaccharides are capable of 
forming complex helices in solution 21–23. The effect of these sugar rings to affect the 
resulting secondary structure has been suggested to be mainly due to the average sugar 
pucker orientation of the furanose envelope or pseudorotational phase angle, which is 
defined by the atom which is displaced furthest from the plane of the other atoms either 
on the same/opposite side of the plane as C5 (endo/exo) 24,25. Additionally, while there 
has been significant interest in developing nucleobases lacking hydrogen bonding and 
more reliant on shape complementarity for base-pairing complementarity 17,26,27, there is 
growing evidence which suggests that a major factor in determining helix stability is due 
to the ability for aromatic nucleobases to base-stack or have quadrupole moment π-π 
interactions 28–31. Presumably, these structural characteristics help produce the most 
important emergent property of XNA- nuclease resistance, by limiting the accessibility of 
the polymer backbone to degradative enzymes 32, yet maintaining the ability for many 
sequence complimentary XNAs to hybridize with natural DNA/RNA and form helices 
33,24.  
From this research, applications of XNA have already begun emerging, mainly in 
therapeutics. The ability for XNAs to be increasingly resistant to endogenous human 
nucleases has been extensively studied and has laid the basis for XNA as effective Anti-
Sense Oligo (ASO) reagents 34,35. It seems the current ultimate measure of an XNA’s 
stability is it’s resistance to 3’ exonuclease snake venom phosphordiesterase, while 
endonucleases ribonuclease H1 and nuclease S1 have also been used throughout literature 
36,34,37–39. Additionally, since many XNA modifications have been found to increase 
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duplex melting temperatures, a measure of helix stability, XNA have also recently found 
applications in enhancing gene-editing platforms, yielding higher target sequence 
specificity as well as lower off-target editing events 40. 
 
Benefits of Glyco-mimetics and Polysaccharide Hybrid Materials 
 
Inherently, glyco-mimetics can be loosely defined as a class of synthetic polymers 
which seek to replicate the activity of natural polysaccharides, glycolipids, and 
glycosylaminoglycans. These natural polymers are instrumental in regulating biological 
systems through intercellular signaling in a structure known as the glycocalyx or 
pericellular matrix. Many integral proteins within the cellular membrane are capable of 
interacting with this glycocalyx covalently by direct glycosylation as glycoproteins or 
non-covalently by as lectin proteins 41. A growing body of evidence suggests that the 
majority of these non-covalent interactions are highly dependent on the binding of several 
glycan epitopes, which are not only specific to the configuration of sugars, but have 
enhanced avidity through multivalency or a precisely evolved length and unique spacing 
of epitopes. 
This allows cells to communicate through chemical non-hormonal means for self-
self-recognition, cell fate determination, and immune response 41,42. Hence, glycol-
mimetics have been a tool to develop various drugs treating aliments such as organ 
rejections following transplantation, paralysis and stem cell research, as well as vaccine 
research 43–46. Indeed, many viruses are known for their relative structural simplicity and 
innate high mutation rate; however, it has been discovered that displayed glycan epitopes 
of viruses are highly conserved, despite rapidly changing primary amino acid sequence, 
since these structures are highly specific for maintaining virulence 47. Hence, research in 
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glycomimetics has led to the development of glycan-epitope specific affinity reagents, 
such as broadly neutralizing antibodies and aptamers. Consequently, by understanding 
how pathogens are capable of selectivity through glyco-science this has also allowed the 
development of cell-specific targeting technologies 48–50.  
The basis of these phenomenon is based in what is known as the cluster glycoside 
effect 51. Several aspects constitute the cluster glycoside effect: it has long been known 
that carbohydrate/ligand-protein interactions are capable of being drastically enhanced by 
increasing saccharide lengths, allowing cell receptors to discriminate between mono- or 
multi-valent saccharide interactions due to the many possible modes available for multi-
receptor binding, multi-ligand binding, or receptor spacing along the membrane 52; this 
clearly suggests, and has been substantiated by experiment, that a successful glycol-
mimetic reagent is capable of optimal binding with increasing similarity to the natural 
receptor epitope in terms of spacing, as well as a unique multivalent ligand 53–55; 
additionally, theoretical experiments suggesting that the physics necessary for binding 
and reception of carbohydrates is similar to the CH-π interactions well known between 
aromatic amino acids and proline 56,57, similarly sharing electron density as in the π-π 
interactions in aromatic previously described in nucleobases, yet capable of doing so 
through hydrogen-bond acceptor/donor interactions 58; the consequence of this 
understanding suggests that not only length or spacing but also the electrostatic 
interactions of each specific carbohydrate within a gylcomimetic have unique electronic 
and steric components 59, which synthetic experiments have substantiated as capable of 
influencing the total avidity of epitope recognition interactions, demonstrating that some 
heterologous glycomimetics have enhanced affinities over homopolymers 60. Considering 
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these holistically, perhaps it is not surprising that another ‘fine-grain’ determinate of 
specific carbohydrate bindings are configurationally specific modifications, specifically 
sulfations or the sulfation code 61,62.  
Current state-of-the science biological hybrid polymers are capable targeting 
specific organ tissues for gene therapy via glyco-conjugation, while preventing rapid 
renal clearance or face liver or kidney accumulation and the resulting toxicity with 
polyethylene glycol (PEG)-conjugation and optimized backbone chemistries 63–69. 
However, while there is a significant ability to augment the specificity and stability of 
such polymers with end-modifications, the overall efficacy and ease of synthesis of the 
core drug can drastically differ. Hence, in addition to main-chain glycol-mimetics which 
seek to emulate naturally occurring polysaccharides and glycosylaminoglycans, several 
side-chain chemistries have been explored to take advantage of the specificity of glycol-
mimetics such as amino acid, XNA, dendrimers, and more traditional polymers 70,44,71,72. 
A complete analysis comparing each of these chemistries in-depth is outside the scope of 
this overview; however it is worth noting some major accomplishments and differences 
in approaches. Particularly, while applications are currently limited in scope, this 
technology could generate a renaissance in drug design by limiting off-target drug effects 
and consequently side-effects, as glycol-mimetics are better understood. 
 
Promise of Aptamer Science over Traditional Affinity Reagents 
 
 There have already been a number of insightful reviews over the years 
specifically detailing the benefits of aptamers over antibodies  and the emerging benefits 
of dendrimers and cationic lipids 68,73. In a general sense, all major monoclonal affinity 
reagents are side-chain polymers which take advantage of the variability of their side-
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chains in order to non-covalently interact with the expected target. For meaningful 
therapeutic applications, multivalency, monodispersity, and cell permeability are also 
highly desired; hence water-soluble sequenced polymers are the standard from a practical 
and analytical standpoint. Antibodies are the human immune systems’ answer to the need 
for affinity reagents in order to fight infectious disease and are well suited to these 
applications; however, the major limitation to the medical applications of antibodies as 
ideal therapeutic agents is the synthetic availability. While selection for antibodies is 
reasonably high-throughput with display techniques, sequence controlled antibodies must 
be generated recombinantly, which is complicated by the necessity to use specialized 
cell-lines expressing non-natural amino acids if the activity of a specific antibody is 
discovered in vivo and requires post-translational modifications, or require solid-phase 
synthesis 74,75.  Significant advances have been made in solid-phase peptide synthesis 
(SPPS), allowing for the reduction of bulk reagents and time from liters and hours into 
milliliters and minutes 76. Additionally, variants on Dawson’s native chemical ligation 
(NCL) process for generating synthetic polypeptides in pieces has allowed SPPS to 
generate small proteins larger than 110 residues or ~12.1 kDa  roughly double the 
traditional limit of about 60 residues or ~ 6.6 kDa 77–80, which can additionally be 
coupled with photo-flow-reactor systems for automation 81; however, while nanobodies 
(Nb-mAbs) also known as single-domain antibodies (sdAb), and bispecific antibodies 
(bs-mAbs) have recently been developed with the aims of significant reducing the 
complexity of traditional antibodies. Nanobodies require only single variable domains 
(VHH), removing the need for immunogenic light variable (VL) domains in the antigen-
binding fragment (Fab) region as single-chain variable fragment (scFv), and even 
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allowing removal of the crystallizable fragment (Fc) region through the linkage of two or 
more Nb-mAbs together. Overally, these advancements are capable of generating Nb-
mAbs at the scales of 15 kDa, increase cell-permeability and structural stability, decrease 
immune responses and aggregation effects, significant “camelization”/residue-specific-
modification, replacing hydrophobic residues with hydrophilic ones,  is necessary to 
allow the  water solubility of these constructs 82. Ultimately, the generation of 
polypeptides via this method requires substantial project specific optimizations, involving 
resign selection and protective group selection; these limit the synthetic accessibility, and 
thus ease of mutant analysis for understanding the mechanisms of action, of evolved 
antibodies 83. Similarly, many dendrimers are in part based on SPPS generated 
polypeptides but assembled using coupling chemistries 84–86. 
 Nucleic acid bases affinity reagents are capable of overcoming many of these 
issues, generally phosphoramidite chemistries regularly allow for coupling efficiencies 
exceeding 99 %  and generation of up to 100 bases 87,88, as previously described are 
amiable specific chemical modifications of drugs in order to increase cell permeability, 
and are capable of selection of targets with sub 20 nM Kd values 89 and epitopes with 
multivalences approaching or equivalent to natural glycan ligands 55,60. It is thus, 
unsurprising that aptamer-hybrid materials are novelly being considered alongside -











Historical Development of XNA Technology 
 
Significant advances in XNA research came in the late 70s; particularly in 
therapeutic applications. While the study of glycomimetics has experienced a resurgence 
in research due to the influx of polymer chemists to this field of study 52,72. Many current 
XNA chemistries were developed to suit similar requirements of genetic therapy. The 
XNA chemistry of 2’-deoxy-2’-Fluoro-Arabinose Nucleic Acid (FANA) has previously 
been utilized as so-called 3rd generation Anti-Sense Oligo (ASO) RNA-based 
therapies34 ; similar chemistries have found successful FDA drug approval, such as the 
2nd generation 2’-O-methoxyethyl (2’MOE) Nusinersen, and 2-O-Methyl (2’OMe) 
Patisiran, and 3rd generation phosphoroamidate morpholino oligomer (PMO) Eteplirsen. 
XNAs open up a new lens in understanding the limitations of traditional 
molecular biology and how scientists should go about understanding the intersections of 
the various disciplines of: systems chemistry, exobiology, synthetic biology, and research 
into the origins of life, in the quest of understanding the molecular world; Xenobiology 
opens the door to the development of new biotechnologies, the ability to synthesize novel 
“never born proteins,” artificially expand genetic information systems, and provides a 
deep understanding of the origin of all Earthly life, in addition to allowing safe and 
ethical scientific progress into ultimately synthesis of wholly man-made organisms. With 
new generations of replicative multiplexed polymerase chain reaction (PCR) and single 
 
11 
nucleotide polymorphism (SNP) sensing available through XNA technology, the largest 
hurdle science has yet to overcome is understanding the advantages and limitations of 
zoo of different XNAs both historically and currently being researched: from humble 
Homo-DNA, isoGs:isoC, dZ:dP, y:x, z:s, xDNA:yDNA, ImON:NaNO & ImNO:NaON, to 
more exotic Q:F, P:H, Ds:Pa, PICS:PICS leading to NaM/MMO2:5SICS, Nd:Md, HNA, 
tc-DNA, CeNA, 2’OMe/SeMe/F/N3, and the almost absurd class of ANA, FANA, TNA, 
GNA, LNA/BNA, PNA, MNA, PMO, and ɑS/B XNAs. Regardless, it seems imperative 
to no longer think of genetic information being stored in the archetypical A, T, C, G, U 
breakthrough scheme that has formed the foundation of modern molecular, especially as 
XNA technology advances to no longer limit itself to single changes in nucleic acids 
either in bases, sugar rings, or polymer linkages. Via the advents compartmentalized self-
tagging-statistical correlation analysis (CST-SCA), the waves of research are already 
being made in attempting to provide the proper cellular machinery in order to allow 
XNAs to not only replicate and be synthesized for use in genetic assays but also to 
reversibly transcribe in vivo, allowing genetic information to be stored and be 
communicated across both DNA and XNA organismal platforms. While full XNA 
organisms may seem to be a reality only the distant future, the pace of genetic technology 
may be compared Moore’s Law and the development of computer electronics, and thus 
the question of when is ultimately an inevitability which may even be tackled with this 
generation of scientists. This highlights many of these historical developments and 
explicitly describes current technology in the development of promiscuous, or “unfussy,” 
polymerases which allow not only the synthesis of a variety XNAs but their reverse 
transcription. This is the beginning of an era where proteins will not be modified to suit 
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purposes but designed de novo and synthesized in orthogonal organisms which safely live 
alongside Earthly-life- anecdotal living aliens from our imaginations. 
 
Historical Overview of Glyco-mimetics and Polysaccharide Hybrid Materials 
 
Polysaccharides have traditionally been in the realm of organic chemists; however 
as research has uncovered the increasing role of not just ligand length but also spacing in 
defining functional multivalency. For an early review of advances in synthetic 
polymerization the review by Grubbs and Grubbs is highly recommended, detailing the 
development of the various methods discovered for controlling and initiating 
polymerization and its origins in from the early 19th century  91. More recently, the 
necessity of sulfation patterns to regulate axon growth, and not necessarily the length of 
polysaccharides was eluciated by a retro-synthetic approach, which accomplished the 
synthesis of a tetrasaccharide from the coupling of two disaccharides, each originating 
from two highly protected  pyrano-sugars 61. The length sugar synthesis of this report 
clearly demonstrated that the activity of chondroitin sulfate gylcosylaminoglycans could 
be replicated in part through synthetically available specific sulfated polysacchirdes. This 
research was further expanded to by generating similarly sulfated side-chain mimetic 
glycopolymer molecules of varying lengths via a  ring opening polymerization strategy  
and controlled by the catalyst concentration 62. This marked a transition of the study of 
glycomimetics into the world of polymer chemistry, as the report demonstrated that 
sulfated disaccharide glycomimetics had an increasing level of axon inhibition with 
increase length, yet overall had a lower activity compared to a sulfated tetrasaccharide 
polymer, synthetically derived from two disaccharide monomers, which additionally had 
activity resembling the natural isolate despite the tetrasaccharide having only a moderate 
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length in comparison to the disaccharide. The functional necessity of 
sulfation/functionalized glycan-ligand multivalency was figured to not be enough to 
define glycosylaminoglycan activity, similar length disaccharide polymers with varying 
numbers and location of sulfations were synthesized via previous methods in order and 
found only to be active when a specific combination or sulfation code was present 43. 
Additionally, this synthetic approach was able to produce a clear application by allowing 
the selection of a specific monoclonal antibody, which novelly was able to selectively 
target a unique class of sulfated natural glycosylaminoglycan and able to additively 
enhance axon regrowth in combination with axon stimulating drugs. 
While the mechanisms of the natural structure-function relationship of 
glycosylaminoglycans were being teased out by organically synthesize or variable length 
polymer glycomimetics, other research was focused on generating gylcomimetics in a 
sequence-specific and monodisperse methodology. This was accomplished by the 
generation of glycomimetics from the Huisgen copper-catalyzed alkyne-azide 
cycloaddition (CuAAC) click amiable triple bond diethylenetriamine succinic acid (TDS) 
‘side-chain’ monomers in combination with a ethylenedioxy succinic acid (EDS) ‘spacer’ 
monomers  assembled via fluorenylmethyloxycarbonyl (Fmoc) protecting group (PG) 
solid-phase synthesis methods 54. The products of this synthesis were capable of 
demonstrating that the spacing of the glycan residues are significant with trivalent side-
chain glycopolymer have ~250 times the activity compared to that of the natural α-
methyl-D-mannose ligand and 8 times the activity as a monovalent polymer of similar 
length, producing a polymer displaying more ligands per total polymer length (7 nm) and 
better approximating the natural lectin binding site distance (6.5 nm). Additionally, this 
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method was superior to previous synthesis as minimal sugar functionalization was 
necessary to generate acetyl protected 2-azidoethyl-O-α-D-mannopyranoside, and the 
resulting polymer was capable of being functionalized prior to resin cleavage, and 
generated with purities ≥ 90 % requiring minimal purification; additionally the use of 
Fmoc methods allowed a mild 25 % piperidine in dimethylformamide (DMF) automated 
deprotection method 80, easy tracking of this deprotection and final resin cleavage 
procedure, as well as allow a asymmetric synthesis using trifluoroacetic acid (TFA) as a 
protecting group starting with a diamine molecule. Variations on this methodology 
utilizing Fmoc, tert-Butoxycarbonyl (Boc), and Allyloxycarbonyl (Alloc) amine 
protection for orthogonal deprotection and functionalization also allow the generation of 
branching monomers 92. Furthermore, by functionalizing TDS monomers with sugars 
immediately following coupling, polymers displaying different glycan species are 
capable of being generated, in addition to having precise polymer length and 
multivalency control 60. Similar work was attempted with the thiol-ene click (TEC) 
chemistry and olefin diethylenetriamine succinic acid (DDS) ‘side-chain’ monomers via 
photo-flow-reactor setup, yet these investigations only seem to have attempted to 
generate hetero-glycomimetics via already glycan functionalized monomers; however, it 
has been previously demonstrated that the CuAAC, TEC, and several click chemistries 
are orthogonal to one another and could be potentially used to functionalize different 
‘side-chain’ DS-like monomers following solid-phase synthesis of the backbone 93,94. 
This generation of hetero-glycomimetics demonstrated that high affinity lectin binding is 
possible to be enhanced by the presence of different species of glycans up to 6 times for 
binding ligands per polymer at surface interfaces, but in solution homo-gylcopolymers 
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are capable of generating aggregate complex due to multi-target interactions, highlighting 
that inclusion of non-binding glycans of varying steric diameter are capable of controlling 
in solution binding modes, especially on flexible backbones. 
Recently, these techniques have been combined in order to synthesis multiblock 
gyclopolymers from a TEC step growth polymerization of DDS-TDS-EDS-TDS-EDS-
TDS-DDS blocks generated from solid-phase synthesis with Cys-EDS5-Cys ‘spacing’ 
blocks, mediated by 2,2-dimethoxy-2-phenylacetophenone (DMPA) radical initiator and 
tris(2-carboxyethyl)-phosphine hydrochloride (TCEP) disulfide reducing agent 95. While 
this method incorporated polymer chemistry techniques leading to the synthesis of 
polydispered polymer with a mass dispersity (M̅w/M̅n, ĐM) of 1.76 – 1.87, typical of a 
step polymerization 96, this allows the efficient synthesis of higher MW glycomimetics, 
similar to the NCL methods of SPPS; this demonstrated that molecules with higher 
multivalency tend to have higher affinity, yet the efficiency per binding ligand efficiency 
tends to maximize at a specific multivalency, independent of the MW of the molecule 
and seemingly the ligand density and not ligand spacing. The emphasis on the total MW 
of glycomimetics is significant for applications of polymer chemistry to gylcomimetics, 
as previous studies in the context of maintaining peptide complex stability suggest that 
while the attachment of polyethylene glycol (PEG) and certain glycoforms of  non-
natural glycosylations were beneficial in decreasing biopolymer immunogenicity in vitro 
and in vivo mice, the increased MW of similar glycosylation modifications was found to 
decrease the mean absorption in dogs, without effects on the biological activity of agent 
97. This demonstrates that glycosylation modification of biopolymers holds promise in 
improving the stability of complex biologically medicines without eliciting immune 
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response and perhaps even decreasing it, here specifically insulin; but, care needs to be 
taken as to the method of glycosylation, as there seems to be an interplay between the 
ability for glycosylated/increased MW drugs to adsorb through tissues and with 
decreasing immunogenicity. In response to these findings, studies utilizing a single 
natural serine/threonine glycosylation of an insulin biopolymer at non-structured regions 
were found to have a similar biological stability to in vitro proteases, 4.7 times higher 
chemical/complex stability, in addition to an increase in the activity of the drug in vitro 
adipocytes; while trigylcosylated glycopolymers were found to have increased biological 
stability, 2.7 times higher chemical/complex stability, with no change in the activity of 
the drug in vitro 98. This seems to suggests that the adage ‘less is more’ holds true, at least 
with the applications of gylcosylations to improve biopolymer stability, without 
decreasing biological activity. 
Current methods to discover natural glycosylations are mostly reliant on glycan 
arrays 99 and mass spectrometry, each of which present unique challenges 100. With 
carbohydrate arrays, discovery of particularly lectin protein specificity to a specific class 
of carbohydrates is reasonably easy but is ultimately limited by the synthetic availability 
of carbohydrates, either from natural sources or current synthetic methods. This in 
particular can be troubling for discovering associations with highly branched glycans, as 
synthetic methods become limited due to the significant combinatorics involved in 
carbohydrate polymers. Respectively, while lectin arrays are becoming more common 
commercially, these suffer from the same combinatorics issues as glycan arrays. 
However, while mass spectrometry does not limit the possible scope of analysis, this 
approach is highly limited by the scope of current glycan databases, additionally this 
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analysis is significantly easier with a priori knowledge of the glycosylated agent, 
particularly proteins. Additionally, considering that some glycans are not available in 
significant quantities for traditional spectroscopic analysis, this is the current standard. 
Recent advances in cryogenic electron microscopy (cryo-EM) allowed the 
specialized analysis of peptide polymers particles larger than 50 kDa and smaller than 
500 nm to a resolution of 3.8 Å within at hydrated or membrane-bound conditions, 
possibly down to a theoretical limit of 38 kDa 101; it is worth noting the key advantage 
that cryo-EM provides is the ability to provide reasonably high-resolution absolute 
structure determination for molecules traditionally difficult to crystalize due to their size, 
such as many proteins, otherwise X-ray diffraction/crystallography (XRD) techniques are 
standard use. Alternatives to XRD have been developed in order to overcome the 
destructive nature of X-rays, specifically using electron diffraction 102, significantly 
requiring fewer and smaller crystals; iteration of this technique in combination with cryo-
EM has developed yet another technique which is perhaps ideal for the analysis of 
polymers smaller than limits afforded from cryo-EM- micro Electron Diffraction 
(MicroED) 103. MicroED is similarly accessible as cry-EM, also utilizing transmission 
electron microscopy, the workflow is also quite similar to that of subtomogram averaging 
(STA) but for the analysis of single-‘nanocrystals,’ and is thus inherently not capable of 
single-particle analysis (SPA) of molecules in native-like conditions 104. Continuous 
rotation methods with microED have proven to be capable of high resolution imaging of 
enzymes (187 kDa)  to a resolution of 1.8 Å 105, 9 residue peptides (816 Da) to a 
resolution of 1.85 Å 106 and  6 residue peptides (905 Da)  to a resolution of 1.1 Å with the 
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addition of divalent heavy metal dopants 107,  and milligram scale heterogeneous 







     





 This study was focused on generating a FANA sequence controlled polymer 
backbone from DNA library templates using minimally modified DNA polymerase 
transcription. These transcripts are designed to additionally incorporate CuAAC clickable 
alkynyl modified uracil bases, replacing all corresponding thymine bases complementary 
to the library adenosines. The incorporation of this modified-DNA base has been 
previously found to be well tolerated in some exonuclease deficient (exo-) DNA 
polymerases; hence, the total synthesis of this FANA base was begun. The incorporation 
of this base into the FANA backbone was designed to allow easy appending of ethyl 
azide saccharides, and subsequently selection for sequence-evolvable and nuclease 




Table 1 – Oligonucleotides used within this study, and their respective sequence. 
All DNA oligonucleotides were purchased from Integrated DNA Technologies. Primers were 
ordered with standard desalting. PCR templates and modified primers were ordered with PAGE 
purification. 














Therminator Seq -1 CTT CCT TAG CTC CTG AAA ATC TC 
Tgo-T5 +1 TCG TCT TCA CCT CGA GAA ATC ATA 
Therminator Seq+1 CAA TTG TGA GCG GAT AAC AAT TTC 
Tgo Seq +1 GTT ATT ACC TGG AAG AAT ATC 
Tgo Seq +2 GAG AGG GAG CTG GCA AGA AG 












ATC CAG AGT GAC GCA GCA N40 (N=A:T:C:G=25:25:25:25)TG GAC ACG GTG 
GCT TAG T 
Heavy DNA lib: 
T-Lib XL 
ATC CAG AGT GAC GCA GCA N40 (N=A:T:C:G=25:25:25:25)TG GAC ACG GTG 
GCT TAG T (AAC)8 
QC DNA Rev: 
T-CY5-RP /5Cy5/ACT AAG CCA CCG TGT CCA 
QC DNA For: 














T1-AM6-FP /5AmMC6//iSp18/ATC CAG AGT GAC GCA GCA 
Forward 2: 
T1-TTB-RC 
/5Hexynyl/TGG ACA CGG TGG CTT AGT 
Forward 1 QC: 
T1-CY5-FC /5Cy5/TGC TGC GTC ACT CTG GAT 
Forward: 
T1-FP ATC CAG AGT GAC GCA GCA 
Reverse: 
T-RP ACT AAG CCA CCG TGT CCA 
QC DNA Reverse: 
T1-Cy5-RP /5Cy5/ACT AAG CCA CCG TGT CCA 
DNA library: 
T1-Lib 
ATC CAG AGT GAC GCA GCA CGG AAC GTC TTT GTA ACT TGA AAT ACC 
GTG GTA GGT TGG CTA GGT TGG ACA CGG TGG CTT AGT 
 
DNA transcription into 2’-Deoxy-2’-Fluoro-Arabinose Nucleic Acids (FANA) 
 
Working initially from protocols developed by a collaborating laboratory 109,110, a 
primer-extension based method was implemented for ‘translation’ of DNA 76-mer 
libraries, consisting of a random region of 40 nt flanked by 18 nt two primer binding 
sequences, into FANA via minimally-mutated polymerases. This work involved 
screening commercially-available polymerases and exonuclease deficient (exo-) 
Thermococcus gorgonarius (Tgo) recombinant polymerase 111- a B-family polymerase 
best known for previous research introducing translesion synthesis 112,113 RNA synthesis 
activity 114,  and overall similarity to Pyrococcus furiosus (Pfu) polymerase 115–117. 
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Recombinant Tgo plasmid verification 
Purified pGDR11-Tgo plasmid (GenBank KP682507.1) was obtained as a 
generous gift from the Chaput laboratory in UC Irvine (carrying the D141A and E143A 
but not D215A exo- mutations 118, responsible for active-site ligand anchoring of two 
divalent ions 119–121) and transformed into electrocompetent TOP10 E. coli cells in SOC 
broth. These cells were incubated overnight at 37 °C and transferred to 100 µg·mL -1 
ampicillin LB-Lennox plates. Colony TempliPhi amplification was used to generate 
transcripts for sequence verification of the transforming plasmid. A 25 % glycerol stock 
and 5 mL liquid culture of verified colony was generated. From the overnight liquid 
culture a SpinSmart miniprep columns with Qiagen buffers were used to reisolate the 
pGDR11-Tgo plasmid. These plasmid were confirmed to be identical by digestion with 
NEB NheI-HF and AvrII or SacI-HF restriction enzymes and ran on a 10 % TAE agarose 
gel in 1X TBE buffer at 200 V for 40 minutes with 0.25 µL·mL-1 ethidium bromide-1X 
TBE staining for 5 minutes (Appendix A). DNA libraries and primers were purchased 
from Integrated DNA Technologies (Coralville, IA). 
Recombinant Tgo expression and purification 
This verified plasmid was transformed into electrocompetent XL1-blue E. coli 
cells. Tgo polymerase expression was induced and was purified from cells using the 
aforementioned previous protocol 109. Briefly, a 100 mL starter culture incoculated a 1 L 
solution of LB-ampicillin to OD600 = 0.6 at 37 °C with shaking at 225 rpm. Expression 
was induced by the addition of 500 μL 1M isopropyl β-D-1-thiogalactopyranoside 
(IPTG) to final concentration of 0.5 mM followed by incubation at 37 °C with shaking at 
225 rpm for four hours. Cells were harvested with centrifugation at 7000 × g for 10 
minutes at 4 °C, resuspended in 40 mL buffer (10 mM Tris, 500 mM NaCl, 10 % 
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glycerol, pH=8.00) for 5 cycles of sonication in a 4 °C cold room, and immediately 
placed into a 80 °C water bath for 60 minutes. The cell lysate was then cooled for 30 
minutes on ice to allow non-heat stable proteins to aggregate, followed by pelleting by 
centrifugation at 40,000 × g for 30 minutes at 4 °C. Nucleic acids were removed from the 
clarified cell lysate by adding 10 % (v/v) polyethyleneimine to a final concentration of 
0.5%, incubating for 15 minutes on ice, followed by pelleting by centrifugation at 40,000 
× g for 20 minutes at 4 °C. The polymerases were precipitated from this supernatant with 
ammonium sulfate powder to a final concentration of 60% (w/v), incubation on ice for 30 
minutes, and centrifugation at 40,000 × g for 30 minutes at 4 °C. This pellet was 
resuspended in a low salt buffer (10 mM Tris, 50 mM NaCl, 10 % glycerol, pH=8.00) 
and clarified by a final centrifugation at 40,000 × g for 8 minutes at 4 °C. Polymerases 
were purified in 10 mL aliquots via fast protein liquid chromatography (FPLC) through a 
GE Healthcare (Chicago, IL) HiTrap Heparin column with a 10x0.5 mL 50, 375, 500, 
1000 mM NaCl step elution program. The fractions were monitored by UV spectroscopy 
at Abs280 on a Thermo Scientific (Waltham, MA) NanoDrop One. The 500 mL fractions 
were reinjected into the column and repurified. Purified polymerase was concentrated 
using Millipore (Burlington, MA) Microcon YM-10 membrane 10k MWCO centrifugal 
microconcentrator and resuspended in a moderate salt, 50 % glycerol buffer (10 mM Tris, 
250 mM NaCl, 50 % glycerol, pH=8.00). Alternatively, dialysis with Thermo Scientific 
Slide-A-Lyzer 20k MWCO MINI Dialysis Cups followed by microconcentrators has 
been used to resuspend the polymerase without glycerol; however, it was found that the 




Recombinant Tgo purification QC 
 Aliquots of proteins throughout the purification process were suspended in 1X 
Cold Harbor Spring sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) loading buffer, denatured by heating for 10 min at 90 °C on the heating block, 
and loaded into Invitrogen (Waltham, MA) NuPage 4-12% Bis-Tris gels with 1X MOPS 
SDS running buffer. Gels were run for 50 minutes at 200 V alongside Thermo Scientific 
PageRuler Plus MW ladder and stained with Coomassie R-250 dye for visualization 
(Figure 1). The final polymerase concentration was determined via the amino acid 
sequence of Tgo (GenBank ALL53335.1) and the ExPASy ProtParam W,Y,C method for 




Figure 1. – Purification of Tgo polymerase expressed in XL1-blue cells. 
PageRuler Plus loaded on each side 2.5 µL each, 10 µL of each purification sample, 5 µL of IPTG 
induced cells after 4 hrs at 37°C with 225 rpm shaking,  and 20 µL of cells prior to cell lysis. 
Polymerase screen for FANA Transcription Activity 
In order to identify the ideal DNA polymerase for transcribing a FANA 
oligonucleotide from a DNA template, New England Biolab’s (Ipswich, MA) Thermus 
aquaticus (Taq), Deep Vent (exo-), Therminator (exo-), and Milipore' Thermococcus 
kodakaraensis (KOD) XL polymerase were screened alongside the previously described 
purified recombinant Tgo polymerase. Each polymerase was selected in order provide a 
different perspective the characteristics necessary for a B family polymerase to accept 
FANA monomers in ThermoPol buffer (20 mM Tris, 10 mM (NH4)2SO4, 10 mM KCl, 
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2.0 mm MgCl2, 0.1 % Triton X-100, pH = 8.8),: Tgo (exo-), as previous mentioned 
lacking 3'→5' proof reading, and is reported as having x26 Taq fidelity as a wildtype 
polymerase 124; Taq polymerase, an A family polymerase and the standard for DNA 
transcription, capable of 5’→3' proof reading and nominal strand displacement, at a 
concentration of 5.0 U·μL-1 ; Deep Vent (exo-), a B family polymerase with similar exo- 
mutations 125,126, thus with limited 3'→5' proof reading but moderate strand displacement, 
and is reported as having x5 Taq fidelity, at a concentration of 2.0 U·μL-1; Therminator 
(exo-), a B family polymerase is a (D141A, E143A, & A485L are known gain-of-
function (gof) mutations to enhance incorporation of unnatural substrates) mutant 9°N 
polymerase 127,114, thus lacking 3’→5' proof reading activity but nominal strand 
displacement (NEB), at a 2.0 U·μL-1 concentration; KOD XL, also known as KOD-Dash 
is a 40:1 mixture of N210D (exo-) and wildtype KOD B family 128, thus with limited 
3’→5' proof reading, has been previously reported to incorporate a wide variety of 
unnatural modified uracil DNA nucleobases 129,130 and was specifically chosen as it has 
been used to generate monosaccharide-modified uracil nucleobase appended 89, at a 2.0 
U·μL-1 concentration in a proprietary reaction buffer.  
The ideal polymerase was identified as having the capability of successfully 
generating full length FANA products, as well as consuming all of the supplied Cy5 
tagged DNA template reverse primer. The fidelity was not examined in this screen, as 
this would be reserved for future studies, once reverse-transcription 
DNA→FANA→DNA capabilities were developed, including modified nucleobases. 
Additionally, this method could potentially be used to study the efficiency kinetics of 




Figure 2. – Tgo-like polymerase displaying known gof RNA transcription mutations 
Pfu polymerase shown interfacing with DNA template via RNA primer, emphasizing key 
mutations: V93Q  responsible for uracil stalling, reducing RNA processivity; A485L the 
‘Therminator’ mutation also known to increase substrate promiscuity; Y409G and E664K steric 
gate mutations discovered alongside TGK, affecting the thumb subdomain, as previously 
demonstrated to be key in maintaining substrate discrimination 27,132–135; and aforementioned  
D141 & E143A (in black text), 3’→5’ exonuclease proof reading mutations, with similar D215A is 
not shown 118. Reproduced without permission from original authors 114. 
Polymerase activity was assessed by primer (XNA) extension (XPE) reactions in 
10 µL reaction volumes containing 1X reaction buffer (ThermoPol or otherwise), 1 µM 
T-Cy5-RP primer, 1 µM T-Lib DNA library, 100 µM of each FANA A/T/G/U xNTPs 
purchased from Metkinen Chemistry (Kuusisto, FIN), and 1 μL polymerase (crude Tgo, 
purified Tgo, Taq, Deep Vent, Therminator, or KOD XL) 109. Primers and templates were 
denatured by heating at 90 °C on a thermocycler for 5 minutes for proper annealing on 
ice for 10 minutes, prior to the addition of polymerase. Upon addition of the polymerase, 
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the samples were incubated for 3 hours at 55 °C. Reactions were quenched with the 
addition of 100 μL (10 equivalents v/v) of 99 % dionized (DI) formamide and 25 mM 
EDTA (ethylenediaminetetraacetic acid) to a final volume concentration of 2.27 mM. DI 
formamide was stored at -20 °C, decanted, and thawed for aliquots in order to maintain 
consistent results. Due to the increased DNA/FANA duplex stability, 15 μL samples were 
denatured at 95 °C on a heating block for 10 minutes, prior to loading onto denaturing 
urea-PAGE gels. After denaturation, samples were loaded onto Invitrogen Novex 10% 
TBE-Urea gel, preheated at 8 W for at least 30 minutes. Gels were run for 60 minutes at 
180 V alongside 1 μL Thermo Scientific GeneRuler Ultra Low Range DNA Ladder with 
5 μL 2X bromophenol blue + xylene cyanol loading dye and a primer-template complex, 
imaged with a Cy5 sensitive channel, and stained with 0.25 µL/mL ethidium bromide-1X 
TBE buffer for composite visualization. 
Polymerase Dilution Series 
Tgo, Therminator, and Deep Vent polymerases were diluted in order analyzing 
the concentration sensitivity of these polymerases in producing full DNA-FANA 
extension, as per previously reported methods 110. The procedure was conducted in 
reaction conditions similar to polymerase screen XPE reactions. Dilutions were made of 
Tgo in moderate salt buffer (10 mM Tris, 500 mM NaCl, 10 % glycerol, pH=8.00) and 
Therminator and Deep Vent were diluted in the respective NEB buffers E & D. Serial 1:1 
dilutions were made to a final dilution of 1:512, providing a measure of the optimal 
polymerase concentration for DNA-FANA extension, as just higher than the 
concentration producing partial extension ‘laddering;’ additionally, these dilutions 
demonstrated that the polymerases did not contain any significant nuclease 
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contaminations by comparing the intensity of the starting material template bands to the 
non-polymerase containing negative control. 
The results of this study found differences between the activity of Deep Vent 
polymerase in the polymerase screen and the dilution series. This suggested that perhaps 
the polymerase storage conditions of polymerases were consequential to the final activity, 
more so than % 50 glycerol prospectively allowing long term cold storage. A batch of 
Tgo polymerase known to have activity at a 1:4 dilution and a batch prepared with 
dialysis and microconcentrators  known to have activity at a 1:8 dilution, were used to 
test the ability of NEB polymerase storage buffer compositions with variable KCl, Tween 
20, IGEPAL CA-630, and Triton X-100 content, in addition to a constant 10 mM Tris, 1 
mM DTT (dithiothreitol), 0.1 mM EDTA, and 50% glycerol, while our Tgo polymerase 
is currently storage in 500 mM NaCl, 10 mM Tris, & 10 % glycerol buffer. Buffer 
exchange was performed using a similar Microcon YM-10 membrane 10 MWCO 
centrifugal microconcentrator, instead replacing the previous volume buffer with a buffer 
augmented with a single additive of interest. 
Tgo Timecourse Optimization 
Tgo diluted 1:4 in a 500 mM NaCl, 10 mM Tris, & 50 % glycerol buffer was 
henceforth used within each procedure involving purified recombinant Tgo polymerase. 
FANA have 18 Da difference from DNA per monomer, allowing PAGE separation of 
FANA from DNA; however, in order to insure high quality FANA separation from DNA, 
a ‘heavy’ DNA library T-Lib XL was used with an extended 3’ region, consisting of 
6xAAC repeats downstream of the primer-binding site (Table 1). This sequence was 
chosen to increase synthetic yield, as purines tend to couple more efficiently than 
pyrimidines on solid-phase. Additionally, this experiment was found to be most 
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successful run at 3X volume conditions, with 3 μL sample aliquots taken at time points in 
30 μL DI formamide with 25 mM EDTA, heated  10 minutes 95 °C and consequently 
cooled on ice for 10 minutes prior to loading on a 1:30 hr 8 W preheated TBE-Urea 
PAGE gel. 
FANA Library Isolation Using RNA PAGE Methods 
In order to generate an adequate amount of FANA library for testing reverse 
transcription conditions as well as anticipating purification losses, 100X scale XPE 
reactions were setup following a protocol similar to the previous XNA XPE reactions. 
Care was taken to split the master mix into PCR tubes with no more than ½ the maximum 
operating thermocycler well volume, in order to maintain optimal heat transfer. However, 
extensions were conducted for 120 minutes, in order to maximize the generation of full 
length product but minimize over-extension by products, and using the ‘heavy’ T-Lib XL 
library as the DNA template. T-Lib XL was critical to this procedure as the additional 5.4 
kDa of mass of the DNA library is approximately 3.9 kDa more massive than the 
produced FANA product; hence, the FANA product runs past the DNA library, 
minimizing the amount of DNA contamination possible, as opposed to the opposite case. 
The reactions were stopped by pooling into a 1 mL LoBind Eppendorf microcentrifuge 
tube (Hamburg, Germany) and 52.63 μL (𝟏 𝟏𝟗⁄  equivalents v/v) 0.5 M EDTA was added to 
a final concentration of 25 mM to stop the reactions. A hole was punched in the cap using 
a 20G needle, frozen in liquid nitrogen for at least 3 minutes, and lyophilized for at least 
6 hours. Afterwards, the sample was a pale blue liquid of approximately 50 μL, the 
volume of the polymerase glycerol. This sample was resuspended in 1 mL DI formamide. 
Samples were denatured for 20 minutes at 95 ºC on a heating block, followed by 10 
minutes cooling on ice. 
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The most efficient purification of the FANA products was investigated in a 
variety of different gel conditions. It was found that loading 25 μL of denatured sample 
into commercial Invitrogen Novex 10% TBE-Urea gels produced reasonable separation 
between the FANA XPE and T-Lib XL library; however, even though preheating for 1 hr 
over 30 minutes was found to produce better band migration, this did not have a 
significant effect on separation (data not shown). These early separation attempts allowed 
isolation of FANA XPE product material or, as was known internally, X-Lib, although it 
did contain DNA contamination (Appendix E). This X-Lib was used to investigate the 
potential separation of 100X XPE reaction products and post-purification purity with 
analytical gel techniques- diluted Cy5-RP, T-Lib, T-Lib XL, purified X-Lib, and XPE 
reactions to concentrations similar to those of previous experiments, 1.36 pmol nucleic 
acid 10:1 in DI formamide (DIF). Self-cast gels were cast using Bio-Rad (Hercules, CA) 
Mini-Protean Tetra Cell 1.5 mm combs. Discontinuous 10 % 19:1/29:1 
stacking/resolving 7.5 M urea TBE and continuous 10 % 29:1 7.5 M urea TBE PAGE 
gels were found to have minimal differences; however, were cast without a gel foot, 
hence there was a tendency for the control primer to run off the gel (Appendix F). The 
final preparative gel conditions allowed loading 500 μL of DI formamide directly into an 
extended 680 μL capacity well on a 12.5 % 29:1 7.5 M urea TBE PAGE gel, preheated 
for 15 minutes at 16 W and ran at 16 W for 30 minutes (Figure 3). These conditions 
allowed UV shadowing of the DNA template library as well as two lower FANA XPE 
product bands that could even be seen by the naked eye under normal library lighting. 




Products were extracted from gels through cutting bands directly from the gel and 
processing by placing one half of the gel slices each into a 500 μL microcentrifuge tube 
with a holed punched via a 20G needle,for centrifugation at 21,000X g for 5 minutes into 
1.5 mL LoBind tubes, followed by either a crush-and-soak or electroelution methods- 
asoaking the crushed gel overnight in 1 mL DPBS overnight 6 at 37 °C with shaking at 
225 rpm; or overnight electroelution in dialysis tubing at 100 V, reversing the polarity for 
2 minutes, and recovering the solution with rinsing in ddH2O. The final slurry was loaded 
into two 800 μL Thermo Scientific 30 μm pore Pierce centrifuge columns or Corning 
(Corning, NY) Costar Spin-X 0.45 μm pore centrifuge tubes and concentrated with 
Millipore Amicon Ultra 3 MWCO MWCO centrifugal microconcentrators into 10 mM 
Tris, pH = 8.00 five times at 10 minutes each into 500 μL LoBind microcentrifuge tubes 
for a combined recovery of 24.0 % or 22.4 %, respectively. Samples were quantified by 
UV spectroscopy at Abs260 on a Thermo Scientific NanoDrop One and the IDT supplied 






Figure 3.  – 12.5 % 29:1 PAGE extraction of 100X FANA XPE & 10 % analytical gel 
The self-cast gel (top) was loaded with 150 pmol T-lib in the reference well to visually track the 
separation of 500 pmol FANA XPE reaction mixture; pre-heated at 16 W for 15 min and run at 16 
W for 30 min. Composite channels allow FANA product (in red) to be clear separated from DNA, 
T-Lib XL (in green). Cut outs indicate the top (DNA) and bottom bands (FANA) were able to be 
excised under UV shadowing (in blue). 10 % 29:1 continuous TBE-Urea analytical gel (bottom): 
15 µL sample at 0.091 µM in DI formamide, 1 hr at 180 V, 1 hr preheated 8 W. 
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DNA Polymerase Mediated FANA ‘Reverse’ Transcription into cDNA 
A preliminary method for ‘reverse’ transcription of the generated FANA library 
back into DNA 110. The DNA polymerases chosen were A family DNA polymerases 
based on the polymerase found in Bacillus stearothermophilus; these polymerases are 
also known for being 3'→5' exonuclease activity deficient 136, while the large fragment of 
this polymerase (Bst LF) is also 5'→3' exo-, similar to Klenow fragment. Bst 2.0 and Bst 
3.0 are mutants based on this Bst LF polymerase, with increasing optimizations for 
isothermal DNA replication and DNA/RNA reverse transcription activity. The 
polymerases were originally screened at the stock concentrations of 5.0 U·μL1, 8.0 U·μL-
1, 8.0 U·μL-1, and 5.0 U·μL-1 respectively; but, were rescreened in concentrations of 1.6 
U·μL-1 and 0.8 U·μL-1 after dilution in NEB buffers D & specific Bst 2.0 buffer. 
The reaction conditions were similar to those of FANA XPE- reactions in were 5 
µL reaction volumes, due to the scarcity of X-Lib material, containing 1X reaction buffer 
(ThermoPol or otherwise) reaction buffer supplemented with 0.3 mM MgCl2, 1 µM T-
Cy3-FP primer (relative to T-Lib), 1 µM X-Lib FANA library, 500 µM of standard 
dNTPs purchased from NEB, and 1 μL  isothermal DNA polymerase (Bst, Bst LF, Bst 
2.0, and Bst 3.0) 109. Primers and templates were denatured by heating at 90 °C on a 
thermocycler for 5 minutes for proper annealing on ice for 10 minutes, prior to the 
addition of polymerase. Upon addition of the polymerase, the samples were incubated for 
3 hours at 50 °C. Reactions were quenched with the addition of 100 μL (10 equivalents 
v/v) of 99 % DI formamide and 25 mM EDTA. These were analyzed in 15 μL volumes 
onto 30 minute 8 W preheated denaturing Invitrogen Novex 10% TBE-Urea gels, ran at 





Click-Particle Display (Click-PD) Selection with Modified Aptamers (SELMA) 
 
The current state-of-the-art method for generating nucleic acid aptamers involves 
the use of Systematic Evolution of Ligands by EXponential enrichment (SELEX). This 
method allows for the systematic amplification of ‘hit’ sequences which are capable of 
binding to a stationary target; however, this method limits the total sequence-scope due to 
the labor intensive screening. A new method to overcome this limitation is Particle 
Display (PD), which works with this paradigm but allowing for a high throughput method 
of screening by functionalizing the aptamer library members to magnetic beads, capable 
of screening ~107 particles/hour, as well as multiparametric simultaneous positive/target 
and negative/non-target selection via a Fluorescence-Activated Cell Sorting (FACS) 
instrument137,138. By anchoring the nucleic acid library to the relatively stationary 
magnetic particles, recombinant fluorescent targets are instead washed over- the inverse 
of SELEX.  
In order to successfully perform PD it is important to generate magnetic particles 
which are monoclonal, only displaying one species of each member of the starting 
nucleic acid library. This is accomplished through emulsion PCR (ePCR). In this 
workflow amino-modified DNA forward primers (T1-AM6-FP, Forward 1) were 
attached to carboxylic acid functionalized Invitrogen Dynabeads MyOne beads via 1-
ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) carbodimmide crosslinking 
chemistry. This requires a specialized forward primer with a 5’ amino group modification 
for covalent coupling, anchoring nucleic acids to the beads during thermal cycling. In 
order to prospectively screen a FANA library, starting from a bead attached DNA library, 
 
35 
a DNA-strand reverse-compliment/XNA-strand forward primer was designed that was 
capable of bead functionalizing with a second coupling chemistry. 
It was found that the bead to phosphorus distance between Forward 1 was found 
to be 33.7 Å from molecular mechanic stimulations on structures built in Avogadro and 
optimized to the Universal Force Field (UFF) 139; hence, utilizing that the functionalized 
FANA library forward primer terminal triple bond modification available through IDT 
(T1-TTB-RC, Forward 2), a comparable distance of 33.0 Å is possible with the additional 
functionalization of an amino-dPEG5-azide linker molecular, available through 
BroadPharm (San Diego, CA), following a CuAAC click coupling.  
Coupling of FP to Magnetic Microparticles 
This method was conducted according to previous methods 137,138. Beads were 
prepared in Eppendorf LoBind tubes for use with a DynaMag magnet; while handling 
beads, care was taken to not keep the magnetic beads longer than 1 min nor to dry, in 
order to prevent aggregation and changes in bead surface chemistry. Invitrogen 
Dynabeads MyOne CA (107/μl) were vortexed and a 500 μL aliquot was washed once 
with 500 μL 0.01 M NaOH, three times with treated Thermo Scientific Ambion non-
DEPC treated nuclease-free water, and resuspended in 150 μL of an EDC reaction 
solution containing 0.2 mM T1-AM6-FP, 200 mM NaCl, 1 mM imidazole chloride, and 
250 mM EDC prepared in dimethyl sulfoxide (DMSO, 50 % v/v). Particles were mixed 
well with three 1 sec vortex pulses and dip sonication, and incubated overnight at room 
temperature on a 10 rpm rotator. 
Prospectively, these beads could be washed with nuclease-free water and the 
above protocol could be repeated with an EDC reaction mixture containing amino-
dPEG5-azide in order to additionally couple and extend the secondary T1-TTP-RC XNA-
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strand forward primer later with the CuAAC click reaction and DNA templating bridge 
amplification. This would allow each bead to essentially contain both a DNA 
‘informational’ and FANA ‘functional’ strand without the need of a ‘reverse 
transcription’ process for aptamer ‘hit’ sequencing. However, it the orthogonality of this 
method remains to be tested. The remainder of this work focuses on merely coupling a 
single library to these beads.  
Surface Pacification of FP-Magnetic Microparticles 
The inclusion of the additional PEG18 spacer between the terminal amino moiety 
and primer sugar was intentional. This minimizes potential interactions of aptamer 
candidates to the particle surface which could potentially lead to false positive selection 
and reduce the functional ‘hit’ library diversity for a target protein. In order to minimize 
undesired nucleic acid/bead-surface interactions, we incorporated a PEG18 molecule as a 
spacer between the particle surface and the forward primer at the 5’ end. However, in 
order to prevent further non-specific surface effects between the beads, the beads were 
pacified in excess with an amino-dPEG12-alcohol molecule purchased from 
BroadPharm.  
The particles were washed with 500 μL 0.1 M (N-morpholino)ethanesulfonic 
(MES), pH 4.7 buffer three times, followed by three 1 sec vortex pulses and dip 
sonication. Beads were then resuspended in a fresh pacification solution containing 100 
mM N-Hydroxysuccinimide (NHS) and 200 mM EDC in cold 0.1 M MES, pH = 4.7 
buffer. Particles were mixed well with three 1 sec vortex pules and dip sonication, and 
incubated for 20 minute at room temperature on a 10 rpm rotator. The use of NHS over 
imidazole is designed to preferentially convert any free bead carboxyls into highly 
amino-reactive NHS-esters; additionally, this step is conducted in MES buffer as the 
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EDC coupling reaction is ideal at low pH values, but the stabilized NHS-ester is capable 
of coupling in physiological pH~7 conditions. 
The particles were then washed two times in 500 μL cold DPBS and resuspended 
in 20 mM amino-dPEG12-alcohol in DPBS buffer. Particles were mixed well with one 1 
sec vortex pulse and dip sonication, and incubated for 30 minute at room temperature or 2 
hours at 4 °C  on a 10 rpm rotator. The reaction was quenched by washing the particles 
once with 500 μL TT buffer (250 mM Tris, 0.1 % v/v Tween 20, pH=8.00) and three 
times with 500 L STT buffer of (10 mM TrisHCl, 0.1 % v/v Tween 20, pH=8.00) 
buffer for storage at in 500 μL STE at 4 °C. 
Testing Conjugation of FP-Magnetic Microparticles 
In order to verify that the coupling of F1-AM6-FP was successful, a Cy5 
fluorescent compliment is hybridized to the beads in order to indicate the presence of the 
primer after washing. Additionally, this is an important checkmark to track whether any 
further optimizations are necessary for the previous steps. To test the conjugation 
efficiency, 5 μL 107 FP-particles were resuspended in 50 μL PBST (1X DPBS + 0.05 % 
v/v Tween 20) in an aluminum foil wrapped microcentrifuge tube and washed three times 
with 50 μL PBST. This 50 μL of 106 particles was again resuspended with 20 μM 
fluorescently-modified T1-CY5-FC in 500 μL PBST room temperature for 30 minutes on 
a 10 rpm rotator. The beads were washed twice with 500 μL PBST before resuspension in 
500 μL for storage. A dilution of 105 beads, 105 FP-particles, and 105 FP-particles + 




Emulsion PCR Generation of Magnetic Microparticles Library 
Generation of the T-Lib-Particle library was conducted according to previously 
reported methods, utilizing only natural dNTPs 94. A PCR reaction was conducted on the 
surface of each bead, by controlling the concentrations of the library to primer-attached-
beads, such that probabilistically each water in oil (w/o) emulsion contains one of each, 
with the addition of a reverse primer in excess. The emulsion PCR mixture was setup 
such that the generated second strand would present a Cy5 fluorescent tag, allowing the 
second strand to be detected only prior to helix denaturation. A 12 μL aliquot of 107 T1-
AM6-FP conjugated particles was resuspended in 1000 μL aqueous reaction mix 
containing 1X Mg-free Taq reaction buffer, 1.5 mM MgCl2, 10 nM T1-FP regenerative 
forward primer, 1 µM T1-Cy5-RP QC DNA reverse primer, 1.5 pM T-Lib DNA library, 
200 µM of each dNTPs purchased from NEB, and 0.05 U·μL-1 Taq polymerase. The 
reaction mixture was transferred to an IKA DT-20 tube and placed on an IKA Ultra-
Turrax device. Over 5 minutes at 620 rpm an emulsion was formed by adding a freshly 
prepared oil phase consisting of biological grade Sigma Aldrich (St. Louis, MO) 4.5% 
Span 80, 0.40% Tween 80 and 0.05% Triton X-100 in mineral oil. This emulsion was 
transferred in 100 μL aliquots to a 96 well plate, sealed with thermal resistant film, and 
run on thermocycler with the following program- 95 oC, 120  sec + [95 oC, 15 sec + 56 
oC, 30 sec + 68 oC, 60 sec]*39 + 68 oC, 300 sec + 4 oC hold. After PCR, Applied 
Biosystems (Foster City, CA) SOLiD emulsion collection trays were attached to the top 
of the trays with adhesive tape, inverted, and spun on a centrifuge at 300 x g for 2 
minutes, in order to transfer the emulsions into the trays. 
The emulsion was broken by adding 10 mL sec-butanol to the tray in 1 mL 
aliquots. Afterwards, the sample was transferred to a 50 mL centrifuge tube and mixed 
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with vortexing for 30 seconds, and spun on a centrifuge at 3,000 x g for 5 minutes, in 
order to pellet the particles. The oil phase was carefully removed and the particles were 
resuspended in 600 μL of emulsion breaking buffer (10 mM Tris, 1 mM EDTA, 100 Mm 
NaCl, and 1% v/v Triton-X) and transferred into a 1.5 mL microcentrifuge tube. The 
remaining supernatant was removed by vortexing for 30 seconds, followed by 
centrifugation at 15,000 x g for 90 seconds, and the use of the DynaMag magnet. The 
particles were washed three times with DPBS buffer and stored in 300 μL PBST. 
Testing Extension Efficiency of Emulsion PCR 
In order to confirm whether the generated T1-particles had the appropriate PCR 
extension ratio of ~20±15 %, necessary for efficient emulsion PCR combinatorics, in 
which adding too little template limits particle-library diversity but adding too much 
template material leads to non-monoclonal beads 137. To test the extension efficiency, 25 
μL 1:25 107 T1-particles were washed once with non-DEPC treated nuclease-free water 
and resuspended in 250 μL 0.1 M NaOH at room temperature for 5 minutes in an 
aluminum foil wrapped microcentrifuge tube on a 10 rpm rotator. The denatured T1-
particles were washed three times with 250 μL nuclease-free water and once with 250 μL 
PBST.  A 50 μL aliquot of these 106 particles was again resuspended in 1 μM 
fluorescently-modified T1-CY5-FC in 500 μL PBST at room temperature for 30 minutes 
on a 10 rpm rotator. The beads were washed twice with 250 μL PBST before 
resuspension in 250 μL for storage.  
A dilution of 105 beads, T1-particles, 105 ssT1-particles + fluorescent tag, and 105 
dsT1-particles + fluorescent tag were analyzed on an Accuri C6+ BD Biosciences FACS 
at 648-668 mm (Figure 8). This procedure was repeated with 500 pM T1-Lib in response 
to preliminary data to reduce the extension efficiency (Figure X). Although this was not 
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conducted, prospectively this should be repeated once more with 250 pM library to 
further reduce the ePCR particle extension efficiency. 
Proposed – FANA ePCR & Click Conjugation of Aptamer Microparticles 
In order to utilize the emulsion PCR technique in order to generate nuclease resistant 
aptamers, it is key that a XNA library members are capable of being attached to the 
magnetic microparticles, as was accomplished with DNA. The ability for KOD XL in 
order to incorporate modified DNA C8-alkyl-uridine triphosphates in the generation of 
DNA aptamers has previously been described 140,89 ; additionally, we have demonstrated 
that Tgo (exo-) and KOD XL have DNA templated FANA transcription activity (Figure 
4). The most ideal path to generating these aptamers may well depend on the future 
results from this project, specifically the activity and fidelity of saccharide clicked- C8-
alkyl-uridine FANA ‘reverse’ transcription back into easily sequenced DNA. This is why 
we have designed a monoclonal two primer (T1-AM6-FP, amino-dPEG5-azide + T1-
TTB-RC) system, if this ‘reverse’ transcription is problematic for functionalized FANA 
aptamers.  
Monoclonal, particle-displaying non-natural C8-alkyl-uridine DNA sequences have 
been previously clicked to monosacchirdes using the CuAAC reaction 89. This allows 
SELMA using FACS for lectin targets, screening for the optimum number of 
multivalency and GAG length necessary for positive selection and  screening against a 
non-target lectin negative selection 138.  Prospectively, the T1-TTB-RC primer would be 
CuAAC clicked to a DNA library + PEG5-azide functionalized magnetic microparticle, 
following emulsion PCR, following a similar procedure as is necessary for click-
conjugation of DNA aptamer particles to saccharides. 
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The optimal conditions for the click-conjugation of azido-sugar monosaccharides was 
previously found to be 0.4 mM Cu(I)Br & 0.4 mM tris((1-benzyl-4-
triazolyl)methyl)amine (TBTA) with acetyl protected 1’ azido-ethyl monosaccharides 
suspended in 100 mM methanol 89. In full, T1-particles are resuspended in an aluminum 
foil wrapped tube with 10 μL DPBS buffer pH 8.0 and degassed for at least 15 minutes 
with N2 bubbling. Afterwards, 25 μL of 20 mM Na2HPO4 and 5 μL 10 % v/v Tween 20 
are added and the click reaction is initiated by the addition of 5 μL 100 mM (methanol) 2-
azidoethyl 2,3,4,6-tetra-O-acetyl-pyranoside  and 2.5 μL of premixed 1:1 solution of 10 
mM (3:1 DMSO:tBuOH ) Cu:TBTA. The reaction tube is mixed well with three 1 sec 
vortex pules, placed into a 20 mL vial with a septum, purged with N2 for 5 minutes. 
Following incubation for 2 hours at room temperature, the dsDNA particles were washed 
five times with 300 μL TE buffer and resuspended in 250 μL 0.1 M NaOH for 5 minutes 
at room temperature on a 10 rpm rotator. The sugars were deprotected from the ssDNA-
particles by resuspension in 300 μL 18 M ammonium hydroxide solution for 3 hours at 
room temperature on a 10 rpm rotator. The final particles are washed five times with 300 
μL TE buffer and stored in 300 μL 10 mM Tris. 
Proposed – Screening of Modified Aptamer Microparticles 
In order to finally screen the generated microparticles for aptamers, the target and 
counter-selection target are necessary. It is proposed that the best counter-selection target 
is a target lectin protein which is within the same clade as the target lectin, but sensitive 
to different ligands. Working from previously reported procedures, denatured modified 
aptamer microparticles are resuspended with 1 nM fluorescently tagged target-lectin 250 
nM differently fluorescently tagged counter-selection target in PBSMCT buffer (1X 
DPBS + 2.5 mM MgCl2, 1 mM CaCl2, 0.01% v/v Tween 20) for 1 hour at room 
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temperature on a 10 rpm rotator 89. It is possible to extend this protocol to alternatively 
screen in biotinylated human serum and label all serum proteins with 50 nM streptavidin-
conjugated fluorescent dye 138. Additionally, SELMA can be enhanced  by, decreasing 
the target lectin concentration every round after 95% of the initial microparticles are 
sorted out and with screening at 37 °C instead of room temperature for the final four 
rounds 55. Similarly, we propose screening could additionally be enhanced by increasing 
the selection entropy with increasing salt concentrations.  
Synthesis of Saccharide Conjugatable Click Facile Base-Modified FANA 
 
 All synthesis targets were verified by NMR spectroscopy in conjunction with 
either Direct Analysis in Real Time (DART) or LC/MS TOF. All heteronuclear 19F-NMR 
spectra were recorded on a Varian 500 MHz H-19F/15N-31P OneNMR PFG probe 
instrument, while 2D NMR spectra were primarily recorded on a Varian 600 MHz 1H-
19F/15N-31P PFG AutoX DB NB probe and a 600 MHz 1H{13C/15N} 5mm PFG 
automation-enabled triple-resonance probe instrument; all spectra were recorded by the 
primary author and cordially maintained by Boston College’s Magnetic Resonance Staff 
Dr. Thusitha Jayasundera & Dr. Jing Jin. Mass spectrometry samples were submitted for 
analysis on JEOL AccuTOF DART or Agilent 6220 Time-of-Flight LC/MS systems, 
based on the expected stability of the generated molecules and overall pre-/post-silica gel 
chromatography purity, by Boston College’s Mass Spectrometry Center’s Dr. Marek 
Domin. The correct synthesis of the β-glycoside was confirmed relative to previous 
reported NMR spectra and by recrystallization followed by X-ray diffractometery. X-ray 
crystals were submitted for analysis on Bruker Kappa Apex Duo by the Boston College’s 




The synthesis was conducted according to previously reported conditions with 
minor modifications 141 and in good agreement with previously reported spectra 142. A 
mixture of uracil (300 mg, 2.68 mmol) and ceric ammonium nitrate (CAN) (733.04 mg, 
1.34 mmol), in MeOH (16 mL) was stirred at 70 °C   for 6.5 hours. Reaction progress 
was monitored by thin layer chromatography (TLC) in EtOAc/i-PrOH/H2O, 4:1:2. The 
solvent was evaporated in vacuo and gave a colorless solid powder that was crystallized 
from 46 mL EtOH/H2O (1:1) to yield two crops of crystals 312.4 mg (with a slight 
orange hue) and 203.7 mg of colorless fine needles. The flask was covered in foil to 
prevent light sensitive damage. Further material was purchased from TCI (Tokyo, JPN) 
1H NMR (500 MHz, DMSO-d6) δ: 11.39 (brs, 1H, NH-3), 11.15 (brs, 1H, NH-1), 7.88 (s, 1 H, H-6). 13C 
NMR (126 MHz, DMSO-d6) δ: 161.46 (C-4), 151.21 (C-2), 146.94 (C-6), 67.56 (C-5). DART-MS m/z: 
238.93216 [M + H]+. 
  
2’-Deoxy-2’-Fluoro-1,3,5-tri-O-benzoyl-α-D-Arabinofuranose 
 The synthesis was conducted according to previously reported conditions with 
minor modifications 143 and in good agreement with previously reported spectra 144. The 
reaction was conducted in oven-dried glassware under a N2 atmosphere in a multi-neck 
round bottom flask. To a stirred solution of 1,3,5-tri-O-benzoyl-α-D-ribofuranose (5.74 g, 
12.41 mmol)  in DCM (86.2 mL), diethylaminosulfur trifluoride (DAST) (6.00 g, 37.22 
mmol, 4.92 mL) was added dropwise at 0 °C  , and the resulting mixture allowed to stir at 
room temperature for 20.5 hr. The reaction progress was monitored by TLC, using DCM 
and developed using 10 % H2SO4 in EtOH staining with heating. The reaction was cooled 
and quenched with saturated aqueous NaHCO3 (57.47 mL). The organic layer was first 
washed with water (2 × 250 mL) and then with saturated aqueous brine (250 mL). This 
was then dried over Na2SO4, filtered and evaporated in vacuo. The crude product was 
purified by silica gel column chromatography using 5.5 cm x 25 cm column with a 10-20 
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g loading capacity; the column was run using 500 mL 8:1 hex:EtOAc in order to first 
remove multi-fluorinated byproducts, followed by a 1 L of 4:1 hex:EtOAc. This yielded 
4.17 g (72.3 %) of sticky yellow oil. 
1H NMR (600 MHz, Chloroform-d) δ: 8.13 – 8.03 (m, 6H, m-Bz), 7.66 – 7.52 (m, 3H, p-Bz), 7.48 – 7.38 
(m, 6H,o-Bz), 6.76 (d, J = 9.1 Hz, 1H, 1’H), 5.64 (dd, J = 19.5, 3.3 Hz, 1H, 3’H), 5.40 (d, JHF = 48.2 Hz, 
1H, 2’H), 4.82 – 4.68 (m, 4H, 4’H & 5’H). 19F NMR (470 MHz, Chloroform-d) δ: -190.84 (ddd, J = 48.1, 
19.6, 9.2 Hz). 13C NMR (151 MHz, Chloroform-d) δ: 166.20, 165.39, 164.49, 133.93, 133.80, 133.20, 
129.94, 129.89, 129.87, 129.77, 129.63, 129.62, 129.16, 129.14, 128.75, 128.73, 128.65, 128.55, 128.41, 
99.48, 99.23, 97.59, 96.36, 84.03, 76.87, 76.66, 63.59. DART-MS m/z: 482.15982 [M + NH4]+.  
 
2’-Deoxy-2’-Fluoro-3,5-di-O-benzoyl-β-D-Arabinofuranosyl-5-Iodourindine 
o Entry 1 
The synthesis was conducted with modifications to similar synthesizes 145,146 utilizing 
an  and in good agreement with previously reported spectra 147,148. A solution of (2’-
Deoxy-2’-Fluoro-1,3,5-tri-O-benzoyl-α-D-arabinofuranose (3.89 g, 8.38 mmol)  was 
azetropically dried with 3x30 mL toluene (at 40 mbar, 40 °C) and 5-iodouracil (2.08 g, 
8.76 mmol)  in anhydrous acetonitrile (ACN) (13.37 mL)  was added N,O-
bis(trimethylsilyl)-acetamide (BSA) (3.66 g, 21.78 mmol, 4.40 mL) and the mixture was 
stirred for 25 minutes at 60 °C. Trimethylsilyl trifluoromethanesulfonate (TMSOTf) 
(5.58 g, 25.13 mmol, 4.86 mL) was added dropwise over 10 min, and stirring was 
continued for another 28:45 hours at 60 °C, after which time TLC analysis (3:2 
hexanes−EtOAc) showed the reaction to be complete. 
The solution became a light yellow-brown color 5-10 minutes after adding BSA, 
and the reaction mixture became a light chestnut oil color immediately after adding the 
TMSOTf Lewis acid. After overnight (O/N), at 14:15 hr after adding the TMSOTf, the 
reaction took on a dark-reddish brown color. 
The mixture was cooled to room temperature, diluted with 27.9 mL (3/2 vol) of 
EtOAc, and poured into 18.6 mL (1 vol) of cold sat. aq. NaHCO3 solution with stirring. 
This yielded unreacted base as a pure white powder, this was filtered off through a Hirsch 
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funnel. The organic layer was then evaporated off under pressure. The organic layer was 
separated and washed with H2O (2x250 mL) and brine (2x250 mL), dried over Na2SO4, 
and concentrated in vacuo. 
After purification, a significant amount of starting materials was recovered- 
2.1549 g of sugar SM and 1.3253 g unreacted base SM, limiting the reaction to a 
theoretical yield of 36.3 %. This clearly indicates that the base is not being activated 
properly, since it is recovered in excess compared to the sugar; while it is possible that 
some sugar is being removed as a salt due to existing as an oxycarbenium ion 149,150, yet 
upon addition of BSA he solution becomes clear, suggesting that all of the base is being 
in fact silylated. Hence, there does not seem to be enough TMSOTf promoter being 
added to drive the reaction. However, 1.18 g of the alpha anomerr and 577.10 mg of the 
beta anomer were recovered. This 2.05:1 alpha:beta ratio, in good agreement to the 
previous report for the use of this starting sugar and Friedel-Craft's catalyst 151. The final 
products are silvery-white in color and include small amounts of dark yellow-orange 
contaminants. This is particularly obvious when running the column, as the beta product 
co-eluted with this contaminant, giving a lime green colored band. The majority of this 
contaminant was leached from the pure beta product by washing the beta product in 
EtOAc and decanting the colored solution off of the white crystal. Additionally, 90.1 mg 
of bis-beta nucleoside product was also recovered, exhibiting a unique NMR signature 
and elution order (data not shown), as expected. 
o 2’-Deoxy-2’-Fluoro-3,5-di-O-benzoyl-α-D-Arabinofuranosyl-Bromide 
In order to explore the potential application of a one-pot sialylation and glycosylation, 
halogenation of the 1’ positioned for a SN2 ‘Walden inversion’ enantioselective β 
glycosylation was conducted with bromine 152. This approach is well documented for the 
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synthesis of inductively hindered 2’halo furanoses and especially bulky nucleobases  153–
155.  The synthesis was conducted without modifications to previous reports 143 and in 
good agreement with previously reported spectra 147. 
The reaction was conducted in oven-dried glassware under a N2 atmosphere in a 25 
mL round bottom flask. The fluoro-arabinose sugar 2’-Deoxy-2’-Fluoro-1,3,5-tri-O-
benzoyl-α-D-arabinofuranose (1.47 g, 3.16 mmol), DCM (7.02 mL) , and 33% HBr 
(5.792 M, 1.64 mL) were stirred for 10.5 hours at 22 °C. Monitoring the reaction with 
DCM TLC. On addition of the HBr, the solution took on a light orange color.  
After 10.5 hours the reaction had a fine ruby orange color. The solution was 
evaporated in vacuo, redissolved in DCM (7.02 mL) , and then washed with water (2x10 
mL) and brine (2x10 mL). The solution was dried with NaSO4 and concentrated to a 
viscous dark red syrup. Following drying over 36 hr on a high pressure vacuum pump 
gave a final yield of 1.2167 g of product for 91.23% isolated yield. Afterwards this was 
azeotropically dried with toluene (3x15 mL), which was further dried under high vacuum 
18 hr. 
1H NMR (500 MHz, Chloroform-d) δ: 8.23 – 8.02 (m, 4H, o-Bz), 7.74 – 7.52 (m, 2H, p-Bz), 7.52 – 7.40 
(m, 4H, m-Bz), 6.64 (d, J = 12.2 Hz, 1H, 1’H), 5.60 (d, J = 50.0 Hz, 1H, 2’H), 5.55 (ddd, J = 22.1, 4.0, 1.3 
Hz, 1H, 3’H), 4.86 – 4.77 (m, 2H, 5’H), 4.72 (dd, J = 11.6, 3.9 Hz, 1H, 4’H). 19F NMR (470 MHz, 
Chloroform-d) δ: -165.95 (ddd, J = 50.0, 22.1, 12.2 Hz). DART-MS m/z: 423.02267 [M + H]+. 
 
o Entry 2 
In a separate 10 mL round bottom, 5-iodouracil base (720.31 mg, 3.03 mmol) was 
dissolved in dry ACN (4.6 mL) BSA (1.52 g, 7.49 mmol, 1.83 mL), was added the 
mixture, and was stirred for 30 minutes at 60 °C. Once the solution was clear, it was 
allowed to cool and the excess silylation agent was removed by evaporation in vacuo to 
afford the silylated 2,4- bis-O-(trimethylsilyl)-5-iodouracil base. To this, NaI (345.67 mg, 
2.31 mmol) was added and was redissolved in dry ACN (793.13 uL). 
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The reaction was conducted in oven-dried glassware under a N2 atmosphere in a 50 
mL round bottom flask. Azeotropically dried fluoro sugar 2-deoxy-2-gluoro-3,5-di-O-
benzoyl-α-D-arabinofuranosyl-bromide (1.22 g, 2.88 mmol) was dissolved in DCM (3.81 
mL). The silylbase solition was injected and the reaction was monitored by TLC 1:1 
hex:EtOAc, showing the reaction to be complete after 99 hrs, or 4 days. 
After adding BSA the first solution became a light yellow-brown orange color, and 
immediately after adding the base the reaction mixture became red orange and slowly 
developed into a light chestnut oil color. After O/N, at 14:15 hours, the reaction took on a 
dark-reddish brown color similar suggesting that this reaction is proceding correctly; 
however also forming colored byproducts. 
The mixture was cooled to room temperature, diluted with 2.88 mL (3/2 vol) of 
DCM, and quenched with 1 mL of cold sat. aq. NaHCO3 solution, filtered through a 
Buchner funnel, washing with CAN. This yielded unreacted base as a pure white powder. 
The organic layer was then evaporated in vacuo to dryness and rediluted in DCM. The 
organic layer was separated and washed with H2O (2x125 mL) and brine (2x125 mL), 
dried over Na2SO4, and concentrated under in vacuum. 
According to TLC after workup, the starting materials side-reacted, likely with the 
residual BSA in solution. 19F-NMR analysis found that the combined integral of these 
sugar byproducts was 2.42 (data not shown), while the alpha and beta were found to have 
a 1.00 and 4.06. This resulted in a 4.06-1 α:β selectivity and a 67.65 % yield, with 
54.28 % the target product. 
o Entry 3 
The reaction was conducted in oven-dried glassware under a N2 atmosphere in a 25 
mL round bottom flask. The day prior, 5-iodouracil was silylated to 2,4- bis-O-
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(trimethylsilyl)-5-iodouracil with HMDS 147. To a mixture of 5-iodo-1H-pyrimidine-2,4-
dione (1.10 g, 4.61 mmol), dry ACN (9.45 mL), was added HMDS (1.68 g, 10.41 mmol, 
2.17 mL) at 40 °C. The resulting mixture was heated at reflux (85 °C) for 24 hr, then 
cooled, and concentrated under reduced pressure to syrup, which was used in the 
subsequent step. On drying, this solution became cloudy. However, this solution was 
capable of being dried in vacuo, as HMDS was counter-intuitively found to be easy to 
evaporate over BSA. 
The next reaction was also conducted in oven-dried glassware under a N2 atmosphere 
in a 50 mL round bottom flask. The fluoro-arabinose sugar 2’-Deoxy-2’-Fluoro-1,3,5-tri-
O-benzoyl-α-D-arabinofuranose (1.62 g, 4.19 mmol), in DCM (5.27 mL), was stirred 
with ACN (1.10 mL) containing the HMDS prepared 2,4- bis-O-(trimethylsilyl)-5-
iodouracil base (1.62 g, 4.19 mmol) and added NaI (478.83 mg, 3.19 mmol)  at 22 °C. 
The reaction was monitored by TLC with 1:1 hex:EtOAc, showing the reaction to be 
complete in approximately 114 hrs, or 4.75 days. 
After adding the base the solution became a light yellow-brown color. After O/N, at 
14:15 hours, the reaction took on a dark-reddish brown color suggesting that this reaction 
is proceeding correctly; however also forming colored byproducts.  
The reaction mixture was worked-up similar to Entry 2. After purification, 129.9 mg 
of the alpha anomer and 687.3 mg of the beta anomer were recovered; however, it was 
found that the formation of a yellow, very EtOAc soluble, decomposition product was 
formed with increased temperature rotovaping. Despite this, we report 4.09-1 α:β 
selectivity, which may well have been higher. 
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o Entry 4 
Similarly to Entry 2, 5-iodouracil base (785.26 mg, 3.30 mmol) was prepared in dry 
ACN (5.02 mL) with BSA (1.66 g, 8.17 mmol, 2.00 mL).To the dry flask, NaI (376.83 
mg, 2.51 mmol, 94.19 uL) was added and was dissolved in dry THF (5.02 mL). 
The reaction was conducted in oven-dried glassware under a N2 atmosphere in a 50 
mL round bottom flask. Azeotropically dried fluoro sugar 2-deoxy-2-gluoro-3,5-di-O-
benzoyl-α-D-arabinofuranosyl-bromide (1.33 g, 3.14 mmol) dissolved in THF (5.02 mL). 
The silylbase solution was injected and the reaction was monitored by TLC 1:1 
hex:EtOAc, showing the reaction to be complete after 99 hrs, or 4 days. 
Unlike the other reactions, after adding BSA the first solution had no change in color. 
After O/N, at 14:15 hours, the reaction took on a dark-reddish brown color similar 
suggesting that this reaction is proceeding correctly; however also forming colored 
byproducts. 
The reaction mixture was worked-up similar to Entry 2. According to TLC after 
workup, the starting materials side-reacted, likely with the residual BSA in solution. 19F-
NMR analysis found that the combined integral of these sugar byproducts was 21.46 
(data not shown), while the alpha and beta were found to have a 1.00 and 13.76. This 
resulted in a 13.76-1 α:β selectivity and a 40.75 % yield, with 37.99 % the target product. 
o Purification 
We found that a silica gel hex:EtOAc gradient of 1.8 L 8:1, 5.4 L 3:1, & 600 mL 
2:1, with a 100 mL 20% MeOH/EtOAc flush, it is possible to get complete separation of 
the SM and each anomer on a 4 cm x 45 cm column. TLC of these gradients suggests that 
only 8:1 and 3:1 are necessary to elute well, holding to a rule of thumb that gives the next 
highest polarity spot have a target Rf of 0.1 in the new solvent, respectively to the sugar 
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SM and the alpha anomer. The 2:1 could still be used to elute the beta anomer, if it is the 
only one left on the column. 
We found the most successful crystals were generated by adding warm DCM until 
the solution was clear, cooling to room temperature, adding hexanes until the solution 
was cloudy, then heating the and adding hexanes dropwise until the solution stayed 
cloudy, followed by one last drop of DCM resulting in a clear solution, producing a light 
cream colored crystal. Afterwards, iPrOH was added with heating to 60 °C, cooling with 
evaporation overnight lightly covered flask in the back of a fumehood, while cooling 
overnight at 4 °C within a refrigerator was found to increase impure precipitates. 
β:1H NMR (600 MHz, DMSO-d6) δ: 11.94 (s, 1H, NH-3), 8.03 (ddd, J = 27.4, 7.8, 1.4 Hz, 4H, o-Bz), 7.99 
(d, J5’H = 2.0 Hz, 1H, H-6), 7.69 (dtt, J = 24.7, 7.5, 1.4 Hz, 2H, p-Bz), 7.55 (dt, J = 21.3, 7.8 Hz, 4H, m-
Bz), 6.30 (dd, J = 19.7, 3.8 Hz, 1H, 1’H), 5.69 (ddd, J = 19.7, 4.7, 1.6 Hz, 1H, 3’H), 5.53 (ddd, JHF = 50.4, 
JHH = 3.9, 1.7 Hz, 1H, 2’H), 4.79 – 4.71 (m, 2H, 5’H), 4.62 (q, J = 4.3 Hz, 1H, 4’H) 
 
α: 1H NMR (600 MHz, DMSO-d6) δ: 11.83 (s, 1H, NH-3), 8.00 (ddt, J = 21.6, 6.9, 1.3 Hz, 4H, o-Bz), 8.20 
(s, 1H, H-6), 7.69 (dtt, J = 11.7, 7.3, 1.3 Hz, 2H, p-Bz), 7.54 (t, J = 7.7 Hz, 4H, m-Bz), 6.19 (dd, J = 17.0, 
1.1 Hz, 1H, 1’H), 5.74 (dt, JHF = 49.3, JHH = 1.7 Hz, 1H, 2’H), 5.71 (dt, J = 17.0, 3.3, 1.8 Hz, 1H, 3’H), 
5.26 (q, J = 4.7 Hz, 1H, 4’H), 4.62 – 4.46 (m, 2H, 5’H) 
 
mix: gHSQC 13C NMR (101 MHz, DMSO-d6) δ: 129.36, 128.90, 144.68, 133.56, 128.51, 83.18, 83.11, 
76.18, 75.86, 91.95, 93.63, 62.95, 78.45//1H NMR (400 MHz, DMSO-d6) δ: 8.05, 8.01, 7.99, 7.70, 7.55, 
6.31, 6.27, 5.72, 5.66, 5.60, 5.47, 4.75, 4.62. 
 
mix: 13C NMR (101 MHz, DMSO-d6) δ: 165.54 (C=O), 164.82 (C=O), 160.28 (C4), 149.71 (C2), 144.95 
(C6),  133.97 (p-Bz), 133.64 (p-Bz), 129.66 (o-Bz x2), 129.24 (o-Bz x2), 129.14 (Bz), 128.87 (m-Bz x2), 
128.80 (m-Bz x2), 128.63 (Bz), 94.04 (β2’H), 92.14 (α2’H), 83.56(β1’H), 83.40(α1’H), 78.76(4’H), 76.47 
(α3’H), 76.17(β3’H), 69.59(C5), 63.26(5’) 
 
mix: 19F NMR (470 MHz, DMSO-d6) δ: -186.57 (dt, J = 49.5, 16.8 Hz, α), -190.90 (ddd, J = 47.2, 19.5, 8.7 
Hz, SM), -199.17 (dt, J = 50.6, 19.9 Hz, β) 
 
β: 1H NMR (400 MHz, Acetone-d6) δ: 10.85 (bs, 1H, NH-3), 8.13 (t, J = 8.2, 7.2 Hz, 4H, o-Bz), 8.10 (d, J = 
3.0 Hz, 1H, H-6), 7.69 (dt, J = 14.1, 7.5, 6.3 Hz, 2H, p-Bz), 7.56 (td, J = 7.5, 4.6 Hz, 4H, m-Bz), 6.41 (dd, J 
= 20.8, 3.2 Hz, 1H, 1’H), 5.77 (dd, J = 19.0, 3.7 Hz, 1H, 3’H), 5.54 (dd, J = 50.5, 3.2 Hz, 1H, 2’H), 4.88 
(dd + t, J = 30.4, 4.0 Hz + J = 5.3, 4.9 Hz, 2H, 5’H), 4.76 (q, J = 3.9 Hz, 1H, 4’H) 
 
α: 1H NMR (500 MHz, Acetone-d6) δ: 8.24 (bs, 1H, H-6), 8.07 (ddd, J = 35.4, 7.2, 1.4 Hz), 7.70 (ddd, J = 
49.3, 5.7, 3.2 Hz), 7.54 (td, J = 7.3, 0.8 Hz), 6.33 (d, J = 15.8 Hz, 1H, 1’H), 5.84 (d, J = 13.9 Hz, 1H, 3’H) 
5.78 (d, J = 48.3 Hz, 1H, 2’H), 5.38 (td, J = 5.6, 2.3 Hz, 1H 4’H), 4.75 – 4.56 (m, 2H, 5’H) 
 
mix: 19F NMR (470 MHz, Acetone-d6) δ: -187.44 (dt, J = 48.4, 15.9 Hz, α), -191.64 (ddd, J = 48.0, 20.3, 




β: 19F NMR (470 MHz, CDCl3) δ: -201.35 (dt, J = 50.2, 19.6 Hz, β) 
 
β: DART-MS m/z: 581.02026 [M + H]+. ESI-MS m/z: 581.020996 [M + H]+. 
 
α: DART-MS m/z: 581.02196 [M + H]+. ESI-MS m/z: 581.021179 [M + H]+. 
 
Trimethyl(octa-1,7-diyn-1-yl)silane 
The reaction was conducted in oven-dried glassware under a N2 atmosphere in a 
100 mL two neck flask. The synthesis was conducted according to previously reported 
conditions with minor modifications 156,157 and in good agreement with previously 
reported mass fragmentation patterns 158. To a solution of 1,7-octadiyne (5 g, 47.10 
mmol, 6.17 mL) in THF (50.00 mL) at -78 °C, waiting 15 minutes to cool, nBuLi (2.5 M, 
18.84 mL) was added slowly over 10 minutes. The mixture was allowed to stir for 20 min 
and then for 1 h at 0 °C. The solution was recooled to -78 °C over 15 minutes, TMSCl 
(5.12 g, 47.10 mmol, 5.98 mL) was added. The mixture was allowed to warm to ambient 
temperature and then stirred for O/N for 19 hours. The reaction was quenched using 5 mL 
of water and the organic solvent was removed in vacuo The layers were washed with the 
addition of 3x50 mL of diethylether and 2x100 mL water and 100 mL brine followed by 
drying of the organic layer over NaSO4. The solvent was removed in vacuo; however, a 
stronger 21 mbar vacuum source was used in combined with single collection flask, 
thermometer, and single distillation column, as per previous procedures. 
Practically, the reported 0.3 mbar with a Vigeraux column is equivalent to my 
conditions, since a simple distillation was used but with higher pressure. 1H-NMR 
anaylsis gave very disperse peaks with little resolution. Additionally, attempting to solve 
for the fractions using the terminal proton and TMS integral gave contradicting numbers. 
Hence, GC-MS was conducted, using the integral under each curve to solve for the 
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composition of each fraction. Overall, 186.4 mg of still material was recovered, 
suggesting 3.73 % of byproducts of heavy alkanes. 
The MS spectra matches the expected mass for the SM–H fragment, product–Me 
fragment, and byproduct–Me fragment, indicating that TMS is in fact being incorporated. 
Using two major fractions were collected and analyzed for further synthesis efforts- the 
first fraction consisted of 2.50 g of material which was composed of 0.02 g SM, 1.82 g 
the target single-TMS product, and 0.65 g double-TMS non-reactive byproducts; and the 
second fraction consisted of 1.63 g of material which was composed of 0.00 g SM, 0.40 g 
target product, and 1.23 g byproducts. Thus, the overall yield of the reaction was 2.23 g 
or 26.49 % and 15.97 % byproducts.  
EI-MS m/z: 105.1 [M – H]–; 163.2 [M – CH4]–; 235.2 [M – CH4]– 
2’-Deoxy-2’-Fluoro-3,5-di-O-benzoyl-D-Arabinofuranosyl-β-C8-alkyl-Uridine 
This screen of synthetic conditions was conducted according to previously reported 
conditions with minor modifications 159,140,160 and in good agreement with previously 
reported spectra 161. The reaction was conducted in oven-dried glassware under a N2 
atmosphere in a 10 mL Schlenk round bottom, 2’-Deoxy-2’-Fluoro-3,5-di-o-benzoyl-β-
D-arabinofuranosyl-5-iodourindine (50.2 mg, 86.51 umol), bis(triphenylphosphine) 
palladium(II) dichloride catalyst (6.07 mg, 8.65 umol), and iodocopper (3.30 mg, 17.30 
umol) solids were dissolved in dry DMF (500 uL), followed by a 3 cycles of freeze-
pump-thaw, over room temperature acetone. Separately prepared N,N-
Diisopropylethylamine (DIPEA) (22.36 mg, 173.01 umol, 29.58 uL)  was freeze-pump-
thawed three times and the stirred reaction mixture. After 10 min at room temperature, 
three times freeze-pump-thawed trimethyl(octa-1,7-diynyl)silane (44.03 mg, 173.01 
umol, 55.04 uL) linker and the reaction was stirred at room temperature for 5:45 hrs. 
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Upon addition of DMF the reaction mixture took on a burnt orange color; upon the 
addition of DIPEA the solution took on a brown color, which developed into a lime green 
with freeze-pump-thaw, ; with the addition of the linker the reaction took on a light cream 
color to which developed into a black color with mixing. The reaction progress was 
monitored by TLC, using with 1:1 hex:EtOAc, and developed using 10 % H2SO4 in 
EtOH staining with heating. The reaction was cooled and quenched with saturated 
aqueous NaHCO3 (57.47 mL). Reaction catalyst was removed by filtering twice through 
celite, with ~30 mL 1:1 DCM:MeOH, in order to avoid leaching the Pd metal again from 
the dark grey celite. The sample was evaporated to a mixture of DMF and MeOH, silica 
gel was added to dry load a 3 cm x 18 cm column, with approximately 250 mg loading 
capacity. We found that a silica gel hex:EtOAc:DCM gradient of 200 mL hex + 1 % 
triethyl amine (TEA), 400 mL 4:1:0, 500 mL 1:1:0, 300 mL DCM to get complete 
adequate separation of the SM and the expected product. All final vials had a dark brown 
coloration, likely due to catalyst impurities. 
TMS: 1H NMR (500 MHz, CDCl3) δ: 8.94 (s, 1H, N3H), 8.07 (dd, J = 25.4, 7.8 Hz, 4H, o-Bz), 7.78 (s, 1H, 
C6H), 7.62 (dt, J = 23.8, 7.4 Hz, 2H, p-Bz), 7.48 (dt, J = 15.8, 7.7 Hz, 4H, m-Bz), 6.32 (d, J = 20.8 Hz, 1H, 
1’H), 5.63 (d, J = 18.0, 1H, 3’H), 5.34 (d, JHF = 45.9, 1H, 2’H), 4.80 (ddd, J = 25.4, 12.1, 4.2 Hz, 2H, 5’H), 
4.54 (m, 1H, 4’H), 2.33 (m, 2H, Alk3H), 2.21 (m, 2H, Alk6H), 1.59 (m, 4H, Alk4H & Alk5H), 0.14 (s, 9H, 
TMS).19F NMR (470 MHz, CDCl3) δ: -201.01 (dtd, J = 50.4, 20.7, 19.9, 2.2 Hz). 13C NMR (151 MHz, 
CDCl3) δ: -201.01 (dtd, J = 50.4, 20.7, 19.9, 2.2 Hz). 13C NMR (151 MHz, o-d6) δ: 166.77 (C=O), 166.06 
(C=O), 160.54 (C4), 150.77 (C2), 146.19 (C6), 134.81 (Bz), 134.39 (p-Bz), 134.37 (p-Bz), 130.82 (o-Bz 
x2), 130.59 (o-Bz), 130.53 (o-Bz), 130.10 (Bz), 129.73 (m-Bz), 129.68 (m-Bz x2), 129.66 (m-Bz), 122.56 
(C5), 100.9 (Alk C1), 94.98 (β2’H), 93.62 (α2’H), 85.55 (β1’H), 85.45 (α1’H), 81.52 (4'), 78.00 (α3'H), 
77.70 (β3H), 73.09 (Alk C2), 70.22 (Alk C7), 68.72 (Alk C8), 64.36 (α5'H), 64.21 (β5'H), 28.53 (Alk C4), 
28.49 (Alk C5), 19.49 (Alk C3), 18.42 (Alk C6), 0.14 (TMS). ESI-MS m/z: 631.227417 [M + H]+. 
 













DNA transcription into 2’-Deoxy-2’-Fluoro-Arabinose Nucleic Acids (FANA) 
 
Nucleic acid aptamers are promising alternatives to antibodies for a wide array of 
diagnostic and therapeutic applications. However, state-of-the-art aptamers suffer from 
poor pharmacokinetics and diversity, limiting their affinity and specificity for many 
therapeutically relevant targets. Combining synthetic chemistry with modern molecular 
biology and polymer science, the synthesis of xeno nucleic acid (XNA) monomers and 
chemoenzymatic polymerization via engineered polymerase enzymes allow the 
production of nucleic acid drugs with superior resistance to endogenous nucleases.  
Polymerase screen for FANA Transcription Activity 
The screening primer extension assay demonstrated that Tgo polymerase, 
Therminator, and KOD XL polymerase produced full length FANA products; however. 
KOD XL did not seem to completely consume the starting DNA primer, suggesting 
limited activity or processivity. Deep Vent (exo-) polymerase seemed to also have limited 




Figure 4.  – DNA polymerase screen for DNA templated FANA transcription 
Loaded with 15 µL samples at 0.091 µM in DI formamide, 1 hr at 180 V, 1:00 hr preheated at 8 
W, 4-12 % TBE-Urea PAGE. Reaction conditions: 3:00 hr, non-diluted polymerases, 25 mM 
EDTA. Ethidium bromide (EtBr) selectively stains DNA T-Lib 78-mer, while staining FANA poorly. 
NT – no template, NP – no primer 
The preferential staining of ethidium bromide stain for DNA over FANA was 
remarkably useful for being able to discriminate between starting material DNA and 
product FANA bands. However, the chosen dsDNA ladder was not informative, as in 
these denaturing conditions it seemed to decompose into several non-descript bands. 
Additionally, it was observed that the addition of the loading dye was deleterious to 
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obtaining an accurate signal, as Cy5 artefacts were observed within lane 1 designating the 
ladder, most likely caused by bromophenol blue (lower) and xylene cyanol (higher). 
However, this method alternatively indicated that lane 2, comprising of DNA library and 
the Cy5-RP without added polymerase, is a respectable relative size standard. This 
negative control consistently allows full-length FANA transcription products to be visible 
from the starting DNA library, as the 18 Da difference in FANA sugars across the length 
of the remaining 58 nts to be approximately 1.5 kDA (including the mass of 5’ Cy5 tag) 
higher in mass, despite the resolution between these bands being inadequate for 
purification purposes. 
Polymerase Dilution Series 
The optimal purified polymerase concentration was determined for optimal XNA 
activity by performing a primer extension assay with FANA xNTPs similarly as to the 
procedure necessary for the polymerase screen. The optimal purified polymerase 
concentration necessary for DNA templated FANA transcription with Tgo was 
determined to 1:8 following recombinant expression and 2x Heparin column purification 
(Figure 4). Since Therminator and Deep Vent (exo-) were also observed to produce 
reasonable additionally determined 1:8 and at most 1:4 respectively (Appendix B & C). 
However, unlike the screening conditions, the Deep Vent polymerase seemingly was 
capable of FANA transcription even without dilute. 
This informed further interrogation of the possibility for polymerase storage 
additives having an enhancing or debilitating effects on FANA transcription, since the 
screening was conducted on a gel additionally containing Tgo polymerase purification 
aliquots with variable salt and glycerol buffer compositions. This follow-up study 
suggests that not only does 50 % glycerol content within a polymerase storage buffer 
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allow -80 deg C storage, but that 50 % glycerol is capable of enhancing Tgo DNA 
polymerase FANA XPE activity (Appendix D). This data could explain why the Deep 
Vent (exo-) polymerase did not generate full length FANA product in the polymerase 
screen, yet in a gel containing only Deep Vent (exo-) polymerase consistently containing 
50 % glycerol, full length transcription of FANA was observed.   
 
Figure 5.  – Tgo dilution series indicating laddering due to polymerase concentration 
Loaded with 15 µL samples at 0.091 µM in DI formamide, 1 hr at 180 V, 1:00 hr preheated at 8 
W, 4-12 % TBE-Urea PAGE. Reaction conditions: 3:00, 0.25 µM Tgo (exo-) polymerase 
(optimum), 25 mM EDTA. EtBr selectively stains DNA T-Lib 78-mer, while staining FANA poorly. 
NT – no template, NP – no primer. Indicates that a 1:4 dilution is optimal, as 1:8 dilution seems to 
have increased incomplete products beneath overlapping DNA band (in yellow). 
Tgo Timecourse Optimization 
The optimal purified polymerase concentration The optimal purified polymerase 
concentration was determined for optimal XNA activity by performing a primer 
extension assay with FANA xNTPs similiarly as to the procedure necessary for the 
polymerase screen. It was observed that the ideal FANA XPE reaction time for Tgo was 
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90 minutes; however, 120 minutes could likely lead to the generation of more product. A 
key utility of these findings were that the final band after 180 minutes was consistently 
aberrant (Figure 1). This band is thought to indicate the generation of overextension by-
products. Additionally, the importance of EDTA concentration was found to be key in 
controlling the rate of FANA extension, as 0.25 mM EDTA was found complete 
extension after at least 150 minutes (data not reported). 
 
Figure 6.  – Timecourse optimization of Tgo Cy5-primer extension into FANA library 
Loaded with 15 µL samples at 0.091 µM in DI formamide, 1 hr at 180 V, 1:30 hr preheated at 8 
W, 4-12 % TBE-Urea PAGE. Optimum reaction conditions: 1:30 hr (2:00 high yield), 0.25 µM Tgo 
(exo-) polymerase, 25 mM EDTA. EtBr selectively stains DNA T-Lib-XL 96-mer, while staining 
FANA poorly. NT – no template, NP – no primer. 
Further work involves the recovery of ‘light’ DNA libraries from FANA libraries, 
following a similar screen for ‘reverse transcription-like’ activity. The goal of this work 
involved the implementation of a primer-based protocol for generating FANA and 
subsequently checking the fidelity of the ‘forward-’ and ‘reverse-translation’ process, 
through FANA.  
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DNA Polymerase Mediated FANA ‘Reverse’ Transcription into cDNA 
It is key that less formamide is not used to resuspend extended FANA samples, as 
the downstream separation becomes more difficult with more concentrated samples. 
Particularly, it was found when XPE products were resuspended with 500 μL (1:2 
μL:pmol) DI formamide the product was not found to UV shadow on an analytical gel 
equivalent to the previous polymerase studies; instead, it was observed that the majority 
of UV shadowing was present on a higher artefact band, due to lack of resuspension of 
ssFANA material and the consequent non-separation of the dsDNA/FANA hybrid helix. 
 
Figure 7.  – Preliminary ‘reverse’ transcription of FANA library with Cy3-primer 
Loaded with 15 µL samples at 0.091 µM in DI formamide, 1 hr at 180 V, 1 hr preheated at 8 W, 4-
12 % TBE-Urea PAGE. Reaction conditions: 3:00 hr at 50 °C, 2.3 mM MgCl2, with variable 
concentration polymerases. EtBr selectively stains DNA 100-mer, while staining FANA poorly. 
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Click-Particle Display (Click-PD) Selection with Modified Aptamers (SELMA) 
 
The modular structure of nucleic acids allows the design of sequence-defined 
polymers capable of post-synthetically appending complex synthetic glycans, extending 
the potential catalytic geometry of aptamers. After breaking the emulsion, Click-PD is 
accomplished by incorporating modified NTPs displaying alkynyl handles facile for the 
Huisgen copper-catalyzed alkyne-azide cycloaddition (CuAAC) reaction to other azide-
reagents89. The optimum monosaccharide reagents for this click reaction have been 
previously determined to be acetyl-protected 1’-azidoethyl pyranoses. Overall, this 
selection of modified-aptamers (SELMA) technique produces glycan-sensitive affinity 
reagents as well as utilizing the library size of the nucleic acid sequence to evolve the 
optimum multivalent number and spacing for binding. 
 
Figure 8. – Conjugation of Cy5-DNA FP to Dynabeads MyOne CA magnetic beads. 
As displayed on Accuri C6+ BD Biosciences. Size and shape of initial particles for flow cytometry 
(left); 640 nm laser excitation and detection of Cy5 fluorescence and bead autofluorescence on 
670 nm LP filter, relative to count of beads before (middle) and after (right). These data indicates 
that roughly half of all beads were labeled with primers following ePCR, suggesting a  even less 
than 0.75 pM DNA library must be used in order to reach the optimum value of ~ 20%137. 
Thus, the preliminary work with DNA library functionalized microparticles 
allows access to the large library diversity and high-throughput ideal for these screening 
procedures. It was found that 99.96 % of beads had different fluorescence profile after 
functionalization, indicating the facile conjugation of amino-primers to these beads 
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(Appendix G). Further work was able identify the sensitivity of these beads to DNA, 
capable of interfacing with as little as 0.75 pmol of DNA in emulsion (Figure 8). 
 
Synthesis of Saccharide Conjugatable Click Facile Base-Modified FANA 
 
The extension of Click-PD technique should allow for individual XNA library 
members to be grown on the surface of the microparticle beads with our proposed two 
primer (T1-AM6-FP, amino-dPEG5-azide + T1-TTB-RC) system . This could be 
accomplished by initially functionalizing the beads with both the amino-forward primer 
and an amino-dPEG5-azide adapter, which is facile for the CuAAC yet utilizing 
orthogonal conjugation chemistry than necessary for functionalizing the bead. This could 
be used to generate an evolvable XNA biopolymer from the template DNA library 
member on each bead, via a bridge amplification primer extension reaction. However, 
this requires the generation of non-commercially available xNTPs. 
Our approach utilizes a Sonogashira cross-coupling reaction to install a flexible 
alkyne to the major groove of 2′-deoxy-2′-fluoro-arabinose uracil base. Uracil was chosen 
as the modified nucleobase, since this base was previously demonstrated to be minimally 
stabilized by the elongated alkyne handle which not only has less steric effects than a 
direct alkyne but also is less likely to destabilize a duplex, overall allowing the highest 
efficiency for click-conjugation162–165. By incorporated recent advances in nucleic acid 
synthesis, one-pot nucleobase activation and sugar glycosylation145,154,166–169 or two-step 
high selectivity143,147,170 can be achieved, additionally we propose to utilize bis-oxybenzyl 
phosphoamidite synthesis in order to generate gram scale HPLC-free purification of 5’ 




Figure 9. – Proposed scheme for synthesis of FANA C8-alklyl-uridine triphosphates. 
These monomers could be useful for either polymerase incorporation into any sequence chain (6) 
or solid-phase synthesis of a target sequence, from the deprotected complete nucleoside (9). 
5-Iodouracil 
 This reaction was previously reported in 80 % isolated yield (Figure 10). We 
reported a similar yield of 81.03 % from two crops of crystals- the first of which had a 
slight orange hue, likely due to light cerium metal impurities. However, the presence of 
these minor impurities was not found to affect the next step of the reaction. While, this 
reaction step was found to be unnecessary as the product was found to be available 
commercially. The utility of this reaction lies within the mechanism, wherein the strong 
oxidative properties of cerium ammonium nitrate (CAN) in situ generate element iodine 
that causes nuclear iodination of electron rich aromatic compounds 172,173, allowing even 




Figure 10. – Nucleobase uracil iodine halogenation mediated by CAN oxidation 
The ideal reaction conditions were with 0.6 mol equiv I2, 0.5 mol equiv CAN are reported to 
functionalize protected and deprotected DNA & RNA nucleosides 141. 
2’-Deoxy-2’-Fluoro-1,3,5-tri-O-benzoyl-α-D-Arabinofuranose 
 Indeed, the majority of these reactions were found to finish the production of 
products after 16 hours with heating to 40 °C. Despite this, while instrumental failure was 
the main cause, it was found that the reaction progresses readily at room temperature, 
even potentially suppressing the generation of multi-fluorinated products. These multi-
fluorinated products were prominently observed with 19F-NMR (data not shown) with a 
larger 10+ gram scale reaction; these by products are the result of DAST’s well 
documented ability to insert germinal fluorines at the position of aldehydes, here the 
benzoyl (Bz) protecting groups (PGs). In an attempt to mediate the potentially hazardous 
properties of DAST reagent, an alternate deoxyfluorinating agent 1.5 mol equiv of 
XtalFluor-E with 1.5 mol equiv DBU was briefly tested 175; however, the resulting 
reaction produced significantly more byproducts (data not shown). These byproducts are 
a non-issue considering the mechanism necessary for the originally planned SN1 Friedel-
Crafts Lewis acid catalyzed Vorbrüggen reaction mechanism (Appendix H) 168,167,152; 
however, their identification and removal became more crucial to minimizing future 
byproducts with the final bromination intermediate mechanism. 
2’-Deoxy-2’-Fluoro-3,5-di-O-benzoyl-β-D-Arabinofuranosyl-5-Iodourindine 
 We report successful synthesis of this molecule using the previously reportedly 
non-productive Vorbrüggen SN1 reaction mechanism (Table 2, entry 1) 147; however, 
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considering the target product is the β anomer, the effective isolated yield is only 11.9 %. 
Hence, a bromination 1’OBz PG SN1 substitution allowed the conversion of 2 into 2’, 
potentially due to the anomeric effect and bromine’s relatively large atomic radius. This 
essentially sets up Br- adducts as a good leaving group allowing amiable SN2 
substitutions to the 2’fluoro-arabino sugar 1’ position, forcing β stereochemistry of the 
nucleobase. A small study was conducted in which the previously reported solvent in 
combination with the 1-pot Vorbrüggen sialyation agent BSA 147,145 (Table 2, entry 2), 
the solvent and weaker sialyation agent as hexamethyldisilazane (HMDS) 147 (Table 2, 
entry 3), and the solvent used in a more recent report for a similar transformation 
alongside the strong BSA sialylation agent 170 (Table 2, entry 4). 
Table 2. – Summary of different FANA glycoside precursor glycosylation conditions. 
The differing effects of glycosylation solvents and base sialyation agents were explored. The 
superior reaction (in italics) was selected based on increased β production, relieving purification 
efforts. 
 
Donor Mech Scale Gylco Temp Solvent 
Sialy 




































 1.86 g 22 °C THF 
2





a – Calculated recovery yield 
b – Isolated yield, including decomposition 
 
These reactions were easily tracked by the generation of a dark reddish brown 
color. Previous failed reactions (data not shown), conducted with large excess TMSOTf 
to be indicative of the formation of N3-nucleoside byproducts, due to the sialylation of 
the formed products. Our hypothesis for this mechanism is that the nucleobase N3 is 
likely being the nitrogen with highest electron density (Appendix H). 
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Heteronuclear 19F-NMR was found to be invaluable in the monitoring of this 
reaction, as it allowed accurate quantification of the α:β ratio of products, even in a crude 
reaction mixture. This was key for screening the selectivity of these reactions, as it was 
found that Entries 2 & 4 underwent side-reactions during the process of drying in vacuo, 
most likely due to the presence of residual BSA reagent. Future work could easily avoid 
this issue, with the addition of another quenching step, allowing the removal of BSA in 
solution and/or low temperature/high vacuum removal of solvent, instead of at 50 °C.  
 
Figure 11. – Bz protected 2-F-arabinose bromine halogenation in glacial acetic acid 
 The ideal reaction conditions were with 0.6 mol equiv I2, 0.5 mol equiv CAN are reported to 
functionalize protected and deprotected DNA & RNA nucleosides 141. 
It was not surprising that Entry 4 was superior reaction since its solvent 
minimized stabilization of a potential SN1 mechanism charged intermediates, producing 
an effective isolated yield of 38.0 % with 93.1 % purity (Figure 11). This reaction was 
selected despite the fact that Entry 2 generated a higher effective isolated yield of 54.3 % 
β anomer but with 80.2 % purity, requiring more precise chromatographic separation of 
diaestereomer. 
This is non-trivial at the preparative scale required for this total synthesis; 
recrystallization was attempted on these products utilizing previously reported 
recrystallization  conditions 1:4 DCM:hex followed by iPrOH 147. This purification 
method was successful in producing a reasonably pure crystal, capable of verifying the 
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absolute orientation of the product via XRD (Figure 12, Appendix I); however, this 
methodology was found to be highly skill-dependent and with low reproducibility, 
recovering 2.91-1 to 21.60-1 α:β purities, as monitored by 19F-NMR.  
 
Figure 12. – X-ray diffractometric structure of FANA glycoside precursor 2’’ 
Reference structure indicates NMR unique hydrogens. This data was generated following iPrOH 
recrystallization. The full crystallographic data is available in Appendix H. Atomic distance 
measurements indicate that crystal self-paired during recrystallization process and NOE between 
C6H and 5’H is possible, as distance is <5Å. 
What was surprising was that the use of a weaker sialyation agent did not drastically 
change the selectivity of the SN2 reactions, as previous reports have found that the 
strength of sialyation agent is capable of increasing β anomer for Vorbrüggen SN1 
reaction mechanism, 176; however, the use of HMDS was found to drastically reduce 
yield of this reaction. This was complicated by the fact that the BSA is reported to have 
very high boiling point, boiling at 71-73 °C at 35 mmHg. However, the TMS resonance 
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forms were calculated to have a lower bp, an estimated 119.6±23.0 °C at 760 mmHg, via 
ChemSpider. Experimentally, it was found that a BSA solution boils at approximately 
35 °C at 50 mbar, and thus easily boil over a water bath of 50 °C. Hence, with the drying 
of HMDS the bump tramp displayed white crystals with evaporation. Additionally, it was 
found that this silylation procedure can actually proceed quite rapidly, within 15 minutes 
at 85 °C, while BSA works similarly within 2 minutes. 
Trimethyl(octa-1,7-diyn-1-yl)silane 
Conducting vacuum distillation using a simple distillation column, it was found 
that the SM, 12 distills around 53 °C, placing the vacuum strength at an apparent strength 
of around 71 mbar (assuming a ACD/Labs Percepta Platform - PhysChem Module on 
ChemSpider.com predicted 35.8 kJ/mol), according to the Clausius-Capryon equations. 
The single-TMS protected product 13 was found to distill around 98 °C. This predicts an 
estimated bp of 188 °C at 1 atm for the product, using the 42.2 kJ/mol estimated by 
ChemSpider; or this estimates 37.1 kJ/mol if using 203.5 °C, as calculated using 
ChemSpider, a better match to the experimental data. Additionally, it was found that in 
an oil bath, the double-TMS protect byproduct 13’ distills around 135 °C; following the 
ChemSpider estimated bp of 264.3 °C at 1 atm, this estimates an enthalpy of vaporization 
of 37.5 kJ/mol- this is likely within error since it does not seem reasonable for the 
enthalpy of vaporization to increase so little with a second TMS group, while it increases 
with a first. Hence, using this logic, using 38.4 kJ/mol (assuming 1.7 increase in 
magnitude per TMS group), the estimated bp is 137 °C, suggesting a good match. If the 
ChemSpider predicted enthalpy of 48.2 kJ/mol is used, then the vacuum bp should be 




Table 3. – TMS Linker distillation with regards to different data sources. 
Data collected from mixed product NMR and GC-MS analysis (Figure 13), alongside calculated 
physical properties and experimental elution temperatures. 
 
 Starting Material Single-TMS Product Double-TMS Byproduct NMR ratio 0 c 0.700 0.300 
area ratio 0.0086 0.7298 0.2616 


























a – experimental data 
b – estimated using physical properties, ACD/Labs Percepta 
c - assumed 
 
In an attempt to clear up the inconsistency in these data, the vacuum line was 
tested in the lab. The house vac gave a reading of 140-160 torr (~200 mbar), while the 
vacuum pump gave 16 torr (21 mbar). This gave ~ 15 kJ/mol lower values, suggesting 
that the boiling points observed would be higher than that observed. This gives credence 
to the strength of the vacuum being in fact smaller than 71 mbar, a highly efficient 
system; since the temperature inside each flask is likely lower than the bath temperature. 
 
Figure 13. – Fraction distillate GC-MS trace containing target product 13 TMS-Linker 
The integral of these traces was used to find the mass ratio of the SM, 12 (in blue), target single-






Initial attempts to conduct this reaction resulted in complex product mixtures that 
required extensive purification and contained many reaction impurities. Although the 
possibility of metal scavangers or an additional post purification reverse-phase activated 
charcoal filtration step was considered, in order to remove the presumed Pd metal 
contamination of the final products, despite silica gel purification, the inability to 
adequately detected the Pd metal (Appendies O) and the proposed additional 5+ steps of 
the proposed reaction pathway (Figure 9) suggested the celite filtration alone was 
sufficient. Additionally, while freeze-pump-thaw techniques were utilized in order to 
generated ‘utmost’ oxygen free samples for the screening, in order to minimize Glaser 
linker-homocoupling byproducts 177, in our experience this step was likely excessive. It 
was found that the largest affect on the reaction mixture purity/control of byproducts was 
by the age of the Pd catalyst. Upon switching to a newly purchased catalyst, regardless of 
type (data not shown), the resulting TLC clearly indicated fewer impurities. 
In response to the widely reported sugar and linker protections presented in the 
literature, a screen of the optimal reaction conditions was initiated in order to identify the 
affect on reactivity that these factors could have on FANA based XNA (Table 4). It was 
identified that, despite literature reports that 10 equivalents non-TMS-protected linker is 
enough to drive this reaction, increasing the equivalents of linker conserves one synthetic 
and purification step; however, with TMS protection only 2 equivalents liker is necessary 
in order to produce a similar result. Preliminary work (data not shown)has also suggested 
that the use of deprotected sugars in order to simply the purification and limit the amount 
of unintended byproducts, considering that the Sonogashira chemistry is insensitive to 
alcohols 178,179.  
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Table 4. – Summary of different FANA -Iodouracil Pd cross-coupling conditions. 
The differing effects of sugar and linker protection were explored. The superior reaction (in italics) 
was selected based high purity and overall step yield, suggesting scalability.  
 
SM purity R1 = R2 R3 
equiv 
linker scale SM Step Yield Purity 





only β Bz H 10 600 mg  1 mmol 6.83 %
b
 pure 





only β Bz TMS 2 50 mg 100 μmol 40.3 %
b
 pure 





only β H TMS 4 200 mg 450 μmol  – – 
a – Calculated recovery yield 
b – Isolated yield, including decomposition 
 
Likely, the additional step of adding acid in order to generate the TMS-linker was 
found to potentially deprotect the nucleoside during cross-coupling (Table 4, entry 3).The 
workflow trade-off in deprotecting subsequent nucleoside one-pot immediately following 
cross-coupling & filtration of the reaction mixture was not explored. However, further 
PG manipulation of a deprotected 5’ would produce a stoichiometrically sensitive 1’ OH. 
 
Figure 14. – Variable FANA-Iodouracil Pd cross-coupling to a variable alkyne linker. 
 Two ideal reaction conditions were identified (Table 4, entry 1 & 4). Any preference between the 
two is very likely one of scale and overall cost. For this reason, both have been identified as being 











DNA transcription into 2’-Deoxy-2’-Fluoro-Arabinose Nucleic Acids (FANA) 
 
Nucleic acid aptamers are promising alternatives to antibodies for a wide array of 
diagnostic and therapeutic applications. However, state-of-the-art aptamers suffer from 
poor pharmacokinetics and diversity, limiting their affinity and specificity for many 
therapeutically relevant targets. Combining synthetic chemistry with modern molecular 
biology and polymer science, the synthesis of xeno nucleic acid (XNA) monomers and 
chemoenzymatic polymerization via engineered polymerase enzymes allow the 
production of nucleic acid drugs with superior resistance to endogenous nucleases.  
Polymerase screen for FANA Transcription Activity 
Indeed, while Tgo polymerase was identified to be a useful polymerase for the 
transcription of DNA into FANA, it should be emphasized that the focus of this work was 
in no manner to identify the optimal FANA polymerase. This is outside the scope of this 
work; however, the previous work to identify functional B family Tgo polymerase 110 and 
the evolution of A family SFM4-3 from the, Klenow-like Stoffel fragment of Taq, DNA 
polymerase 180–182. With this in retrospect, the activity of Klenow (-exo) fragment 
polymerase compared to Klenow and Klentaq could have additionally been screened, in 
order to determine if it was in fact the 3’→5’ proof reading activity of Taq polymerase 
that made FANA transcription inactive or if this was due to a larger structural 
morphology affecting substrate promiscuity. 
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DNA Polymerase Mediated FANA ‘Reverse’ Transcription into cDNA 
There exist many polymerases which are Mn+2 dependent for unnatural 
promiscuity and activity, such as for incorporating unnatural nucleobases or sugars. 
While the current scope of this research project does not make any efforts to directly 
mutate polymerases on a grand scale, in order to overcome these limitations. It was found 
that the mechanism for Mn+2 to impart RNA template reverse transcription-like 
properties in A family DNA polymerases, could be related to the ability for DNA 
polymerase to accept unnatural substrate. This has been reported to be caused by the 
divalent metal ion catalyzed hydrolysis of RNA into shorter sequences 183, this seems a 
plausible explanation for the observations of reverse transcription activity in –exo B 
family DNA polymerases superior or similar to that of obligate AMV RNA polymerase 
with RNA templates up to 125 nts 184. Regardless, we have identified potential new 
mutations to induce in Tgo or Tgo-like Pfu B family polymerases, in order to better 
harness this mechanism. 
Click-Particle Display (Click-PD) Selection with Modified Aptamers (SELMA) 
 
The bead to terminal oxygen distance for the pacification PEG was found to be 
45.0 Å; while it is unsure whether this value is critical for appropriate screening, as to the 
authors’ knowledge this has not been screened in previous literature, and as it stands the 
pacification would be approximately equal in length to the other reagents with 9 PEG 
units at 34.4 Å. Ultimately, this presents further potential for process optimization and the 
screening of further conditions. 
Additionally, it is not known whether each of the proposed screening methods is 
ideal for only glycoprotein or glyconucleaic acids. It would be particularly surprising to 
discover that each method additionally is compatible with one another. For instance, 
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while our proposed increased salt concentration gradient theoretically would produce an 
increasing entropic penalty, similar to increased temperature conditions, it may be likely 
that this could cause serum protein aggregation. Thus, indirectly forcing selection 
for/against large protein aggregates, or even the target of interest. Regardless, the ability 
to screen for targets in human serum, as well as at physiological conditions of 37 °C, 
would certainly be a boon for selecting for interaction of ‘true’ binding partners, in 
addition to providing a better in vitro model for in vivo therapeutic conditions. 
Synthesis of Saccharide Conjugatable Click Facile Base-Modified FANA 
 
Although the synthesis target was not reached during the primary author’s 
duration of time spent on this project, the proposed synthesis route would allow the 
generation of the reagents necessary to allow the screen of novel modified FANA 
aptamers. The produced C8-alkyl-uridine FANA triphosphates could be incorporated by 
an engineered Tgo (exo-) DNA polymerase to allow systematic introduction of alkynyl 
conjugation handles into a DNA-templated FANA polymer. Subsequent conjugation with 
azido-modified glycans via the CuAAC click reaction would generate sequence 
controlled nucleic acid-carbohydrate hybrid molecules amendable for directed evolution. 
Additionally, this synthesis places the phosphoramidite within reach185, allowing solid-




The great variability in the ability for XNA to take and sustain a great variety of 
different structures could very well someday allow individual companies to develop their 
own strains of living cells which utilize a proprietary genetic polymer system to store or 
even, at very least, translate biological information- orthogonally to all other living or 
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currently known beings. While this may seem excess today, as this technology further 
develops along its experience curve and the barriers to entry is further reduced, this could 
be a conceivable measure in order to control in vivo intellectual property and/or provide 
ultimate biosafety, more so than metabolic limitations 186. Already there are mounting 
concerns for the need of biodefense in this “post-genomic age” 187; however, this only 
seems to highlight a major limitation in this technology- the inability for it to be rapidly 
sequenced de novo nor a priori without knowledge of the chemical makeup of an XNA 
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Tgo Plasmid RD QC Agarose Gel 
 
 
Restriction digests of TOP10 isolated pGDR11-Tgo & pGDR11-KOD RI 
plasmids treated with NEB NheI-HF (2,5) and AvrII (3,6) or SacI-HF (4,70), restriction 
enzymes, loaded alongside Puc19 with SacI-HF (8) with reference to 1 kb Plus 
GeneRuler DNA ladder (1). Ran on a 10 % TAE agarose gel in 1X TBE buffer at 200 V 









Therminator XPE Dilution Series 
 
 
Therminator dilution series, conducted similarly to Tgo polymerase (Figure 5), displaying 
less laddering. Lanes increase 2X in dilution from left to right. Loaded with 20 µL 
samples at 0.091 µM in DI formamide, 1 hr at 180 V, 1:00 hr preheated at 8 W, 4-12 % 
TBE-Urea PAGE. Optimum reaction conditions: 1:30 hr (2:00 high yield), 0.25 µM Tgo 
(exo-) polymerase, 25 mM. EtBr selectively stains DNA T-Lib 78-mer, while staining 
FANA poorly. NP – no polymerase (leftmost most); NT – no template (right most).  
Black and white composite indicates overlapping bands with white. DNA T-Lib is clearly 









Deep Vent (exo-) XPE Dilution Series 
 
 
Deep Vent (exo-) dilution series, conducted similarly to Tgo polymerase (Figure 5), 
displaying less laddering. Lanes increase 2X in dilution from left to right. Loaded with 20 
µL samples at 0.091 µM in DI formamide, 1 hr at 180 V, 1:00 hr preheated at 8 W, 4-
12 % TBE-Urea PAGE. Optimum reaction conditions: 1:30 hr (2:00 high yield), 0.25 µM 
Tgo (exo-) polymerase, 25 mM. EtBr selectively stains DNA T-Lib 78-mer, while 
staining FANA poorly. NP – no polymerase (left most); NT – no template, no DNA 
libary (right most). Black and white composite indicates overlapping bands with white. 










Tgo Storage Additives Study 
 
 
Loaded with 15 µL samples at 0.091 µM in DI formamide, 1 hr at 180 V, 1:00 hr 
preheated at 8 W, 4-12 % TBE-Urea PAGE. The KCl concentration over NaCl was not 
tested; however, Tween 20 IGEPAL CA-630, Triton X-100 was not found to be 
beneficial to enhancing FANA XPE activity (data not reported). However, excessive 
DDT was found to negatively affect FANA XPE activity, while 50 % glycerol was found 
to positively affect FANA XPE activity. The effect of EDTA was not found to be 
significant at the tested concentration. Mix – DNA library and primer, no polymerase; 









DIF Purity and Early Gel Extractions of X-Lib 
 
 
Effect of formamide purity was assayed using two different suppliers of 
formamide- synthesis grade Fisher/Thermo Scientific & Affymetrix/USB Biochemicals 
(Santa Clara, CA) UltraPure formamide. While results are minimal, it was observed that 
formamide purity, assayed via 1H-NMR & 13C-NMR (data not reported), correlated with 
tighter band width. Although X-Lib through gel extraction (GE) was primarily FANA 
material, some DNA contamination is still detectable. Samples were loaded in 15 μL 








DIF Purity and Early Gel Extractions of X-Lib 
 
 
Samples were loaded in 15 μL aliquots, except for X-Lib loaded at 25 μL due to 
low concentration, 10:1 formamide and 1X XPE concentrations (1.36 pmol) of nucleic 











FP-Particle Encapsulation Affinity 
 
 
Bio-Rad S3 Cell Sorter-FACS captured 5000 events of 1:100 T1-AM6-FP functionalized 107 Dynabeads 













2’-Deoxy-2’-Fluoro-D-arabinofuranosyl Glycosylation Mechanisms & Conditions 
 








Crystal data and structure refinement for C23H18FIN2O7 
 
Identification code    C23H18FIN2O7 
Empirical formula    C49 H44 F2 I2 N4 O15 
Formula weight    1220.68 
Temperature     100(2) K 
Wavelength     1.54178 Å 
Crystal system     Orthorhombic 
Space group     P212121 
Unit cell dimensions   a = 9.7073(3) Å a= 90°. 
     b = 21.2291(7) Å b= 90°. 
     c = 23.6686(9) Å g = 90°. 
Volume     4877.6(3) Å3 
Z     4 
Density (calculated)   1.662 Mg/m3 
Absorption coefficient   10.832 mm-1 
F(000)     2440 
Crystal size    0.480 x 0.120 x 0.090 mm3 
Theta range for data collection  2.796 to 66.649°. 
Index ranges    -11<=h<=11, -15<=k<=24, -28<=l<=28 
Reflections collected   32826 
Independent reflections   8325 [R(int) = 0.0402] 
Completeness to theta =   66.649° 99.6 %  
Absorption correction   Semi-empirical from equivalents 
Max. and min. transmission  0.7528 and 0.4461 
Refinement method   Full-matrix least-squares on F2 
Data / restraints / parameters  8325 / 2 / 658 
Goodness-of-fit on F2   1.027 
Final R indices [I>2sigma(I)]  R1 = 0.0246, wR2 = 0.0576 
R indices (all data)   R1 = 0.0261, wR2 = 0.0581 
Absolute structure parameter  0.039(3) 
Extinction coefficient   n/a 




Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) for 
C23H18FIN2O7.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
 x y z U(eq) 
I(1) 6796(1) 9765(1) 3472(1) 22(1) 
F(1) 12089(3) 9466(1) 3591(1) 24(1) 
O(1) 11297(3) 8339(1) 4206(1) 21(1) 
O(2) 10497(3) 7560(2) 2821(1) 23(1) 
O(3) 6490(3) 8628(1) 2620(1) 24(1) 
O(4) 14503(3) 8256(2) 3881(1) 21(1) 
O(5) 15674(4) 8456(2) 4682(1) 28(1) 
O(6) 11109(3) 8836(1) 5272(1) 21(1) 
O(7) 11647(4) 9626(2) 5862(1) 28(1) 
N(1) 10226(4) 8467(2) 3340(2) 19(1) 
N(2) 8508(4) 8107(2) 2730(2) 18(1) 
C(1) 11537(5) 8362(2) 3618(2) 19(1) 
C(2) 12648(5) 8861(2) 3532(2) 21(1) 
C(3) 13558(5) 8745(2) 4045(2) 20(1) 
C(4) 12532(5) 8524(2) 4502(2) 19(1) 
C(5) 9800(5) 8012(2) 2952(2) 16(1) 
C(6) 7624(5) 8594(2) 2846(2) 19(1) 
C(7) 8131(5) 9039(2) 3264(2) 17(1) 
C(8) 9376(5) 8955(2) 3503(2) 19(1) 
C(9) 15574(5) 8170(2) 4243(2) 21(1) 
C(10) 16596(5) 7696(2) 4035(2) 22(1) 
C(11) 16320(5) 7302(2) 3576(2) 22(1) 
C(12) 17292(5) 6857(2) 3419(2) 27(1) 
C(13) 18530(5) 6809(2) 3710(2) 30(1) 
C(14) 18803(6) 7210(2) 4157(2) 31(1) 
C(15) 17834(5) 7656(2) 4321(2) 26(1) 
C(16) 12207(5) 9049(2) 4910(2) 25(1) 
C(17) 10907(5) 9195(2) 5732(2) 20(1) 
C(18) 9679(5) 8990(2) 6062(2) 20(1) 
C(19) 9507(5) 9238(2) 6604(2) 25(1) 
C(20) 8408(6) 9039(2) 6935(2) 29(1) 
C(21) 7481(5) 8596(2) 6728(2) 31(1) 
C(22) 7640(5) 8360(2) 6189(2) 30(1) 
C(23) 8741(5) 8550(2) 5855(2) 24(1) 
I(2) 6283(1) 5805(1) 1547(1) 23(1) 
F(2) 2436(3) 7260(1) 678(1) 23(1) 
O(8) 1074(3) 6639(1) 1646(1) 21(1) 
O(9) 7188(3) 7164(1) 2056(1) 22(1) 
O(10) 3104(3) 8191(2) 2156(1) 26(1) 
O(11) -997(3) 7650(1) 978(1) 21(1) 
O(12) -2508(3) 7022(2) 529(1) 25(1) 
O(13) 1171(3) 5962(1) 649(1) 22(1) 
O(14) 565(4) 5009(2) 327(2) 31(1) 
N(3) 3101(4) 7196(2) 1778(2) 18(1) 
N(4) 5110(4) 7647(2) 2121(2) 20(1) 
C(24) 1640(4) 7249(2) 1631(2) 19(1) 
C(25) 1398(5) 7490(2) 1031(2) 21(1) 
C(26) 41(5) 7182(2) 872(2) 20(1) 
C(27) -93(5) 6613(2) 1272(2) 19(1) 
C(28) 3831(5) 6671(2) 1629(2) 19(1) 
C(29) 5194(5) 6623(2) 1721(2) 18(1) 
C(30) 5936(5) 7147(2) 1972(2) 18(1) 
C(31) 3724(5) 7715(2) 2028(2) 19(1) 
C(32) -2259(5) 7513(2) 771(2) 19(1) 
C(33) -3254(5) 8028(2) 871(2) 21(1) 
C(34) -2884(5) 8574(2) 1164(2) 27(1) 
C(35) -3851(6) 9050(2) 1233(2) 31(1) 
C(36) -5159(6) 8986(2) 1013(2) 31(1) 
C(37) -5533(5) 8443(2) 723(2) 28(1) 
C(38) -4585(5) 7958(2) 661(2) 23(1) 
C(39) -79(5) 5986(2) 975(2) 23(1) 
C(40) 1390(6) 5430(2) 346(2) 24(1) 
C(41) 2771(5) 5425(2) 84(2) 24(1) 
C(42) 3194(6) 4884(2) -199(2) 31(1) 
C(43) 4514(6) 4849(3) -414(2) 37(1) 
C(44) 5422(6) 5345(3) -348(2) 34(1) 
C(45) 5009(6) 5894(3) -72(2) 31(1) 
C(46) 3691(6) 5932(2) 142(2) 26(1) 
O(15) 648(5) 8905(2) 2060(2) 48(1) 
C(47) -452(8) 9876(3) 1951(4) 62(2) 
C(48) 896(8) 9520(3) 1883(3) 52(2) 



















13C-NMR Spectrum in DMSO 
 









DART Mass Spectrum 
 









1H-NMR Spectrum in CDCl3 
 









1H-NMR Spectrum in CDCl3 
 









19F-NMR Spectrum in CDCl3 
 









19F-NMR Spectrum in CDCl3 
 









13C-NMR Spectrum in CDCl3 
 









13C-NMR Spectrum in CDCl3 
 









gCOSY Spectrum in CDCl3 
 









gCOSY Spectrum in CDCl3 
 









DART Mass Spectrum in CDCl3 
 









1H-NMR Spectrum in CDCl3 
 









19F-NMR Spectrum in CDCl3 
 









DART Mass Spectrum 
 









1H-NMR Spectrum in DMSO 
 









1H-NMR Spectrum in DMSO 
 









1H-NMR Spectrum in Acetone 
 









1H-NMR Spectrum in DMSO 
 









1H-NMR Spectrum in DMSO 
 









1H-NMR Spectrum in Acetone 
 









19F-NMR Spectrum in DMSO 
 









19F-NMR Spectrum in Acetone 
 









19F-NMR Spectrum in CDCl3 
 









13C-NMR Spectrum in DMSO 
 









gCOSY Spectrum in Acetone 
 









gCOSY Spectrum in DMSO 
 









gHSQC Spectrum in DMSO 
 









DART Mass Spectrum 
 









DART Mass Spectrum 
 









ESI Mass Spectrum 
 













ESI Mass Spectrum 
 













1H-NMR Spectrum Temperature Study in DMSO 
 
Investigation of C6H doublet coupling to 5;H in only β isomer, alongside reference 
structure. Temperature modulated (left to right) 20 °C (in red), 50 °C (in green), 70 °C (in 









1H-NMR Spectrum Temperature Study in DMSO 
 
Investigation of C6H doublet coupling to 5;H in only β isomer, alongside reference 
structure. N3H upfield shifting indicating increased shielding likely due to change in 









1H-NMR Spectrum Temperature Study in DMSO 
 
Investigation of C6H doublet coupling to 5;H in only β isomer, alongside reference 
structure. 5’H coupling changes from multiplet into doublet as proposed conformational 









1H-NMR Spectrum Temperature Study in DMSO 
 
Investigation of C6H doublet coupling to 5;H in only β isomer, alongside reference 
structure. C6H coupling changes from doublet into singlet as proposed conformational 









1H-NMR Spectrum in CDCL3 
 
Spectrum of distillation fraction, indicating mixture of product and byproducts. 
Integrands below indicate molar ratio due to each proton (arrows) Data in Figure 13 









1H-NMR Spectrum in CDCl3 
 









19F-NMR Spectrum in CDCl3 
 









13C-NMR Spectrum in Acetone 
 









gCOSY Spectrum in CDCl3 
 









ESI Mass Spectrum 
 













ESI Mass Spectrum 
 
Chemical analysis of silica gel column purified product, alongside reference structure. 
 
 
 
 
